10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 10-Q

(Mark One)

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                     to                    

Commission file number 000-04065

Lancaster Colony Corporation

(Exact name of registrant as specified in its charter)

Ohio	13-1955943
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
37 West Broad Street Columbus, Ohio	43215
(Address of principal executive offices)	(Zip Code)

614-224-7141

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated filer	ý	Accelerated filer	¨
Non-accelerated filer	o  (Do not check if a smaller reporting company)	Smaller Reporting Company	¨

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes  ¨    No  ý

As of April 24, 2015, there were 27,357,000 shares of Common Stock, without par value, outstanding.

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION		3
Item 1.	Condensed Consolidated Financial Statements (unaudited):
	Condensed Consolidated Balance Sheets – March 31, 2015 and June 30, 2014	3
	Condensed Consolidated Statements of Income – Three and Nine Months Ended March 31, 2015 and 2014	4
	Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended March 31, 2015 and 2014	5
	Condensed Consolidated Statements of Cash Flows – Nine Months Ended March 31, 2015 and 2014	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	21
Item 4.	Controls and Procedures	21
PART II – OTHER INFORMATION		22
Item 1A.	Risk Factors	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22
Item 6.	Exhibits	22
SIGNATURES		23
INDEX TO EXHIBITS		24

2

PART I – FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(Amounts in thousands, except share data)	March 31,   2015			June 30,   2014
ASSETS
Current Assets:
Cash and equivalents	$	161,417		$	211,539
Receivables (less allowance for doubtful accounts, March-$194; June-$432)	69,374			57,808
Inventories:
Raw materials	29,951			28,069
Finished goods	42,319			46,447
Total inventories	72,270			74,516
Deferred income taxes and other current assets	26,128			23,428
Total current assets	329,189			367,291
Property, Plant and Equipment:
Land, buildings and improvements	112,836			107,690
Machinery and equipment	253,537			238,791
Total cost	366,373			346,481
Less accumulated depreciation	190,878			177,807
Property, plant and equipment-net	175,495			168,674
Other Assets:
Goodwill	126,723			89,840
Other intangible assets-net	51,696			5,376
Other noncurrent assets	8,127			7,449
Total	$	691,230		$	638,630
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	43,796		$	37,907
Accrued liabilities	33,226			31,165
Total current liabilities	77,022			69,072
Other Noncurrent Liabilities	20,868			22,208
Deferred Income Taxes	23,969			18,753
Commitments and Contingencies
Shareholders’ Equity:
Preferred stock-authorized 3,050,000 shares; outstanding-none
Common stock-authorized 75,000,000 shares; outstanding – March-27,356,804 shares; June-27,339,421 shares	107,020			104,789
Retained earnings	1,206,136			1,167,211
Accumulated other comprehensive loss	(7,874		)	(8,061		)
Common stock in treasury, at cost	(735,911		)	(735,342		)
Total shareholders’ equity	569,371			528,597
Total	$	691,230		$	638,630

See accompanying notes to condensed consolidated financial statements.

3

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)

	Three Months Ended   March 31,						Nine Months Ended   March 31,
(Amounts in thousands, except per share data)	2015			2014			2015			2014
Net Sales	$	263,400		$	241,849		$	826,798		$	782,267
Cost of Sales	206,775			189,941			634,096			591,565
Gross Margin	56,625			51,908			192,702			190,702
Selling, General and Administrative Expenses	25,417			23,073			76,674			69,251
Operating Income	31,208			28,835			116,028			121,451
Interest Income and Other-Net	(138		)	(204		)	(177		)	(328		)
Income From Continuing Operations Before Income Taxes	31,070			28,631			115,851			121,123
Taxes Based on Income	10,667			9,731			39,733			41,038
Income From Continuing Operations	20,403			18,900			76,118			80,085
Discontinued Operations, Net of Tax:
Income from discontinued operations	—			325			—			3,175
Loss on sale of discontinued operations	—			(29,601		)	—			(29,601		)
Total discontinued operations	—			(29,276		)	—			(26,426		)
Net Income (Loss)	$	20,403		$	(10,376	)	$	76,118		$	53,659
Income Per Common Share From Continuing Operations:
Basic and diluted	$	0.75		$	0.69		$	2.78		$	2.93
Loss Per Common Share From Discontinued Operations:
Basic and diluted	$	—		$	(1.07	)	$	—		$	(0.97	)
Net Income (Loss) Per Common Share:
Basic	$	0.75		$	(0.38	)	$	2.78		$	1.97
Diluted	$	0.75		$	(0.38	)	$	2.78		$	1.96
Cash Dividends Per Common Share	$	0.46		$	0.44		$	1.36		$	1.28
Weighted Average Common Shares Outstanding:
Basic	27,303			27,261			27,294			27,258
Diluted	27,330			27,297			27,323			27,303

See accompanying notes to condensed consolidated financial statements.

4

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

	Three Months Ended   March 31,						Nine Months Ended   March 31,
(Amounts in thousands)	2015			2014			2015			2014
Net Income (Loss)	$	20,403		$	(10,376	)	$	76,118		$	53,659
Other Comprehensive Income:
Defined Benefit Pension and Postretirement Benefit Plans:
Amortization of loss, before tax	100			109			300			325
Amortization of prior service asset, before tax	(1		)	(1		)	(3		)	(3		)
Total Other Comprehensive Income, Before Tax	99			108			297			322
Tax Attributes of Items in Other Comprehensive Income:
Amortization of loss, tax	(38		)	(41		)	(111		)	(120		)
Amortization of prior service asset, tax	1			1			1			1
Total Tax Expense	(37		)	(40		)	(110		)	(119		)
Other Comprehensive Income, Net of Tax	62			68			187			203
Comprehensive Income (Loss)	$	20,465		$	(10,308	)	$	76,305		$	53,862

See accompanying notes to condensed consolidated financial statements.

5

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended   March 31,
(Amounts in thousands)	2015			2014
Cash Flows From Operating Activities:
Net income	$	76,118		$	53,659
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	14,937			15,596
Deferred income taxes and other noncash changes	2,527			5,144
Stock-based compensation expense	2,211			1,777
Excess tax benefit from stock-based compensation	(456		)	(927		)
Gain on sale of property	—			(6		)
Loss on sale of discontinued operations	—			44,027
Pension plan activity	(444		)	(182		)
Changes in operating assets and liabilities:
Receivables	(8,981		)	(10,813		)
Inventories	5,996			7,901
Other current assets	(1,853		)	(13,602		)
Accounts payable and accrued liabilities	6,508			(3,779		)
Net cash provided by operating activities	96,563			98,795
Cash Flows From Investing Activities:
Cash paid for acquisition, net of cash acquired	(92,217		)	—
Payments on property additions	(15,752		)	(8,143		)
Proceeds from sale of property	—			6
Proceeds from sale of discontinued operations	—			25,616
Other-net	(1,410		)	(854		)
Net cash (used in) provided by investing activities	(109,379		)	16,625
Cash Flows From Financing Activities:
Purchase of treasury stock	(569		)	(3,120		)
Payment of dividends	(37,193		)	(34,960		)
Excess tax benefit from stock-based compensation	456			927
Decrease in cash overdraft balance	—			(324		)
Net cash used in financing activities	(37,306		)	(37,477		)
Net change in cash and equivalents	(50,122		)	77,943
Cash and equivalents at beginning of year	211,539			123,385
Cash and equivalents at end of period	$	161,417		$	201,328
Supplemental Disclosure of Operating Cash Flows:
Cash paid during the period for income taxes	$	37,835		$	36,941

See accompanying notes to condensed consolidated financial statements.

6

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Note 1 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and SEC Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the results of operations and financial position for such periods. All such adjustments reflected in the interim condensed consolidated financial statements are considered to be of a normal recurring nature. The results of operations for any interim period are not necessarily indicative of results for the full year. Accordingly, these financial statements should be read in conjunction with the financial statements and notes thereto contained in our 2014 Annual Report on Form 10-K. Prior-year results reflect the classification of the sold candle manufacturing and marketing operations as discontinued operations. Unless otherwise noted, the term “year” and references to a particular year pertain to our fiscal year, which begins on July 1 and ends on June 30; for example, 2015 refers to fiscal 2015, which is the period from July 1, 2014 to June 30, 2015.

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation, except for those acquired as part of a business combination, which are stated at fair value at the time of purchase. Purchases of property, plant and equipment included in accounts payable and excluded from the property additions and the change in accounts payable in the Condensed Consolidated Statements of Cash Flows were as follows:

	March 31,
	2015		2014
Construction in progress in accounts payable	$	489	$	1,465

Accrued Distribution

Accrued distribution costs included in accrued liabilities were $6.1 million and $6.4 million at March 31, 2015 and June 30, 2014, respectively.

Earnings Per Share

Earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock and common stock equivalents (restricted stock and stock-settled stock appreciation rights) outstanding during each period. Unvested shares of restricted stock granted to employees are considered participating securities since employees receive nonforfeitable dividends prior to vesting and, therefore, are included in the earnings allocation in computing EPS under the two-class method. Basic EPS excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing income available to common shareholders by the diluted weighted average number of common shares outstanding during the period, which includes the dilutive potential common shares associated with nonparticipating restricted stock and stock-settled stock appreciation rights.

7

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Basic and diluted income per common share from continuing operations were calculated as follows:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Income from continuing operations	$	20,403		$	18,900		$	76,118		$	80,085
Income from continuing operations available to participating securities	(26		)	(21		)	(109		)	(139		)
Income from continuing operations available to common shareholders	$	20,377		$	18,879		$	76,009		$	79,946
Weighted average common shares outstanding – basic	27,303			27,261			27,294			27,258
Incremental share effect from:
Nonparticipating restricted stock	2			2			3			3
Stock-settled stock appreciation rights	25			34			26			42
Weighted average common shares outstanding – diluted	27,330			27,297			27,323			27,303
Income per common share from continuing operations – basic and diluted	$	0.75		$	0.69		$	2.78		$	2.93

Reclassifications Out of Accumulated Other Comprehensive Loss

The following table presents the amounts reclassified out of accumulated other comprehensive loss by component:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Accumulated other comprehensive loss at beginning of period	$	(7,936	)	$	(8,256	)	$	(8,061	)	$	(8,391	)
Defined Benefit Pension Plan Items:
Amortization of unrecognized net loss (1)	107			115			321			345
Postretirement Benefit Plan Items:
Amortization of unrecognized net gain (1)	(7		)	(6		)	(21		)	(20		)
Amortization of prior service asset (1)	(1		)	(1		)	(3		)	(3		)
Total other comprehensive income, before tax	99			108			297			322
Total tax expense	(37		)	(40		)	(110		)	(119		)
Other comprehensive income, net of tax	62			68			187			203
Accumulated other comprehensive loss at end of period	$	(7,874	)	$	(8,188	)	$	(7,874	)	$	(8,188	)

(1) Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

Significant Accounting Policies

There were no changes to our Significant Accounting Policies from those disclosed in our 2014 Annual Report on Form 10-K.

8

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Recently Issued Accounting Standards

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (“ASU 14-09”) which creates a comprehensive set of guidelines for the recognition of revenue under the principle: “Recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” The requirements of ASU 14-09 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2016 and will require either retrospective application to each prior period presented or retrospective application with the cumulative effect of initially applying the standard recognized at the date of adoption. We are currently evaluating the impact this ASU will have on our financial position and results of operations.

Note 2 – Acquisition

On March 13, 2015, we acquired all of the issued and outstanding capital stock of Flatout Holdings, Inc. (“Flatout”), a privately owned manufacturer and marketer of flatbread and pizza crusts based in Saline, Michigan. The purchase price, net of cash acquired, was $92.2 million and was funded by cash on hand. The purchase price is subject to the finalization of cash and net working capital adjustments. Flatout is reported in our Specialty Foods segment, and its results of operations have been included in our condensed consolidated financial statements from the date of acquisition, but such results were not material to our condensed consolidated financial statements.

The following preliminary purchase price allocation is based on the estimated fair value of the net assets acquired, as adjusted for the estimate of the final net working capital of $0.2 million recorded as of March 31:

Balance Sheet Captions	Allocation
Receivables	$	2,532
Inventories	3,748
Other current assets	512
Property, plant and equipment	7,198
Goodwill (not tax deductible)	36,883
Other intangible assets	47,100
Current liabilities	(2,310		)
Deferred tax liabilities	(3,225		)
Net assets acquired	$	92,438

Further adjustments are expected to the allocation above as the third-party valuation is finalized and certain tax aspects of the transaction and a customary post-closing review are completed during the measurement period.

The goodwill recognized above arose because the purchase price for Flatout reflects a number of factors including the future earnings and cash flow potential of Flatout and the avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance our existing product offerings and enter the supermarket deli department. Goodwill also results from the workforce acquired with Flatout.

We have determined the preliminary values and lives of the other intangible assets listed in the allocation above as: $37.6 million for the tradename with an indefinite life; $5.0 million for the customer relationships with a 10-year life; $3.9 million for the technology / know-how with a 10-year life and $0.6 million for the non-compete agreements with a 5-year life. We will continue to evaluate these values and lives during the measurement period.

Pro forma results of operations have not been presented herein as the acquisition was not considered material to our results of operations.

9

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Note 3 – Goodwill and Other Intangible Assets

Goodwill attributable to the Specialty Foods segment was $126.7 million and $89.8 million at March 31, 2015 and June 30, 2014, respectively. The increase in goodwill is the result of the acquisition of Flatout on March 13, 2015. See further discussion in Note 2.

The following table is a rollforward of goodwill from June 30, 2014 to March 31, 2015:

	Carrying Value
Goodwill at beginning of year	$	89,840
Goodwill acquired during the period	36,883
Goodwill at end of period	$	126,723

The following table summarizes our identifiable other intangible assets, all included in the Specialty Foods segment. The intangible asset values and lives related to the Flatout acquisition, which are included in the table below, are preliminary and subject to further review over the measurement period. See further discussion in Note 2.

	March 31,   2015			June 30,   2014
Tradename (indefinite life)
Gross carrying value	$	37,600		$	—
Trademarks (40-year life)
Gross carrying value	$	370		$	370
Accumulated amortization	(221		)	(214		)
Net carrying value	$	149		$	156
Customer Relationships (10 to 15-year life)
Gross carrying value	$	18,020		$	13,020
Accumulated amortization	(8,531		)	(7,800		)
Net carrying value	$	9,489		$	5,220
Technology / Know-how (10-year life)
Gross carrying value	$	3,900		$	—
Accumulated amortization	(32		)	—
Net carrying value	$	3,868		$	—
Non-compete Agreements (5-year life)
Gross carrying value	$	600		$	—
Accumulated amortization	(10		)	—
Net carrying value	$	590		$	—
Total net carrying value	$	51,696		$	5,376

Amortization expense for our other intangible assets was as follows:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Amortization expense	$	308	$	236	$	780	$	709

10

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Total annual amortization expense for each of the next five years is estimated to be as follows:

2016	$	1,785
2017	$	1,614
2018	$	1,614
2019	$	1,614
2020	$	1,574

Note 4 – Long-Term Debt

At March 31, 2015 and June 30, 2014, we had an unsecured credit facility (“Facility”) under which we may borrow, on a revolving credit basis, up to a maximum of $120 million at any one time, with potential to expand the total credit availability to $200 million based on obtaining consent of the issuing banks and certain other conditions. The Facility expires on April 18, 2017, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternative base rate defined in the credit agreement, at our option. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Based on the long-term nature of this Facility, when we have outstanding borrowings under this Facility, they will be classified as long-term debt.

At March 31, 2015 and June 30, 2014, we had no borrowings outstanding under this Facility. At March 31, 2015, we had $4.2 million of standby letters of credit outstanding, which reduced the amount available for borrowing on the Facility. We paid no interest for the three and nine months ended March 31, 2015 and 2014. At March 31, 2015 and June 30, 2014, we exceeded the requirements of the financial covenants by substantial margins.

The Facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions. There are two principal financial covenants: an interest expense test that requires us to maintain an interest coverage ratio not less than 2.5 to 1 at the end of each fiscal quarter; and an indebtedness test that requires us to maintain a consolidated leverage ratio not greater than 3 to 1 at all times. The interest coverage ratio is calculated by dividing Consolidated EBIT (as defined more specifically in the credit agreement) by Consolidated Interest Expense (as defined more specifically in the credit agreement), and the leverage ratio is calculated by dividing Consolidated Debt (as defined more specifically in the credit agreement) by Consolidated EBITDA (as defined more specifically in the credit agreement).

Note 5 – Income Taxes

Prepaid Federal, state and local income taxes of $10.3 million and $9.7 million were included in deferred income taxes and other current assets at March 31, 2015 and June 30, 2014, respectively.

The gross tax contingency reserve at March 31, 2015 was $1.0 million and consisted of tax liabilities of $0.6 million and interest and penalties of $0.4 million. We have not classified any of the gross tax contingency reserve as current liabilities as none of these amounts are expected to be resolved within the next 12 months. The entire liability of $1.0 million was included in other noncurrent liabilities. We expect that the amount of these liabilities will change within the next 12 months; however, we do not expect the change to have a significant effect on our financial position or results of operations. We recognize interest and penalties related to these tax liabilities in income tax expense.

Note 6 – Stock-Based Compensation

Our shareholders previously approved the adoption of and subsequent amendments to the Lancaster Colony Corporation 2005 Stock Plan (the “2005 Plan”). The 2005 Plan reserved 2,000,000 common shares for issuance to our employees and directors, and all awards granted under the 2005 Plan will be exercisable at prices not less than fair market value as of the date of the grant. The vesting period for awards granted under the 2005 Plan varies as to the type of award granted, but generally these awards have a maximum term of five years.

Stock-Settled Stock Appreciation Rights

We use periodic grants of stock-settled stock appreciation rights (“SSSARs”) as a vehicle for rewarding certain employees with long-term incentives for their efforts in helping to create long-term shareholder value. We calculate the fair value of SSSARs grants using the Black-Scholes option-pricing model. Our policy is to issue shares upon SSSARs exercise from new shares that had been previously authorized.

11

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

In the nine months ended March 31, 2015 and 2014, we granted SSSARs under the terms of the 2005 Plan. The following table summarizes information relating to these grants:

	Nine Months Ended   March 31,
	2015			2014
SSSARs granted	149			146
Weighted average grant date fair value per right	$	9.94		$	11.84
Weighted average assumptions used in fair value calculations:
Risk-free interest rate	0.86		%	0.75		%
Dividend yield	2.02		%	1.97		%
Volatility factor of the expected market price of our common stock	19.62		%	22.35		%
Weighted average expected life in years	2.71			3.12

For these grants, the volatility factor was estimated based on actual historical volatility of our stock for a time period equal to the term of the SSSARs. The expected average life was determined based on historical exercise experience for this type of grant. The SSSARs we grant vest one-third on the first anniversary of the grant date, one-third on the second anniversary of the grant date and one-third on the third anniversary of the grant date. As needed, we estimate a forfeiture rate for our SSSARs grants based on historical experience.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification. We recorded tax benefits and excess tax benefits related to SSSARs. These excess tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes our continuing operations SSSARs compensation expense and tax benefits recorded:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Compensation expense	$	308	$	304	$	893	$	804
Tax benefits	$	108	$	106	$	313	$	281
Intrinsic value of exercises	$	207	$	2,343	$	863	$	2,431
Excess tax benefits	$	72	$	820	$	302	$	851

The total fair values of SSSARs vested were as follows:

	Nine Months Ended   March 31,
	2015		2014
Fair value of vested rights	$	1,245	$	1,138

12

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

The following table summarizes the activity relating to SSSARs granted under the 2005 Plan for the nine months ended March 31, 2015:

	Number of Rights		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of year	358		$	76.75
Exercised	(54	)	$	63.54
Granted	149		$	91.13
Forfeited	(31	)	$	79.42
Outstanding at end of period	422		$	83.35	3.73	$	4,984
Exercisable and vested at end of period	154		$	74.70	2.66	$	3,150
Vested and expected to vest at end of period	412		$	83.35	3.73	$	4,873

At March 31, 2015, there was $2.3 million of unrecognized compensation expense related to SSSARs that we will recognize over a weighted-average period of 2 years.

Restricted Stock

We use periodic grants of restricted stock as a vehicle for rewarding our nonemployee directors and certain employees with long-term incentives for their efforts in helping to create long-term shareholder value.

In the nine months ended March 31, 2015 and 2014, we granted shares of restricted stock to various employees under the terms of the 2005 Plan. The following table summarizes information relating to these grants:

	Nine Months Ended   March 31,
	2015		2014
Employees
Restricted stock granted	9		24
Grant date fair value	$	845	$	2,190
Weighted average grant date fair value per award	$	91.13	$	89.21

The restricted stock under these employee grants vests on the third anniversary of the grant date. As needed, we estimate a forfeiture rate for our restricted stock grants based on historical experience. Under the terms of our grants, employees receive dividends on unforfeited restricted stock regardless of their vesting status. In the nine months ended March 31, 2015 and 2014, 19,000 and 6,000 shares, respectively, of employee restricted stock vested.

In November 2014 and 2013, we granted shares of restricted stock to our nonemployee directors under the terms of the 2005 Plan. The following table summarizes information relating to each of these grants:

	Nine Months Ended   March 31,
	2015		2014
Nonemployee directors
Restricted stock granted	7		6
Grant date fair value	$	639	$	490
Weighted average grant date fair value per award	$	92.92	$	84.42

The 2015 grant vests over a one-year period, and all of these shares are expected to vest. Dividends earned on the stock during the vesting period will be paid to the directors at the time the stock vests. In the nine months ended March 31, 2015 and 2014, 6,000 and 7,000 shares, respectively, of nonemployee director restricted stock vested, and the directors were paid the related dividends.

13

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification. We recorded tax benefits and excess tax benefits related to restricted stock. These excess tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes our continuing operations restricted stock compensation expense and tax benefits recorded:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Compensation expense	$	384	$	366	$	1,318	$	1,027
Tax benefits	$	134	$	128	$	461	$	359
Excess tax benefits	$	142	$	68	$	154	$	76

The total fair values of restricted stock vested were as follows:

	Nine Months Ended   March 31,
	2015		2014
Fair value of vested shares	$	1,818	$	877

The following table summarizes the activity relating to restricted stock granted under the 2005 Plan for the nine months ended March 31, 2015:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of year	58		$	79.09
Granted	16		$	91.89
Vested	(25	)	$	71.86
Forfeited	(3	)	$	79.22
Unvested restricted stock at end of period	46		$	87.61

At March 31, 2015, there was $2.6 million of unrecognized compensation expense related to restricted stock that we will recognize over a weighted-average period of 2 years.

Note 7 – Pension Benefits

We sponsor multiple defined benefit pension plans that covered certain union workers. However, as a result of prior-years' restructuring activities, for all periods presented, we no longer have any active employees continuing to accrue service cost or otherwise eligible to receive plan benefits. Benefits being paid under the plans are primarily based on negotiated rates and years of service. We contribute to these plans at least the minimum amount required by regulation.

The following table summarizes the components of net periodic benefit income for our pension plans:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Components of net periodic benefit income
Interest cost	$	403		$	439		$	1,209		$	1,315
Expected return on plan assets	(658		)	(614		)	(1,974		)	(1,842		)
Amortization of unrecognized net loss	107			115			321			345
Net periodic benefit income	$	(148	)	$	(60	)	$	(444	)	$	(182	)

For the three and nine months ended March 31, 2015, we made no pension plan contributions and we do not expect to make any contributions to our pension plans during 2015.

14

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share data)

Note 8 – Postretirement Benefits

We and certain of our operating subsidiaries provide multiple postretirement medical and life insurance benefit plans. We recognize the cost of benefits as the employees render service. Postretirement benefits are funded as incurred.

The following table summarizes the components of net periodic benefit cost for our postretirement plans:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Components of net periodic benefit cost
Service cost	$	8		$	8		$	24		$	24
Interest cost	27			33			81			97
Amortization of unrecognized net gain	(7		)	(6		)	(21		)	(20		)
Amortization of prior service asset	(1		)	(1		)	(3		)	(3		)
Net periodic benefit cost	$	27		$	34		$	81		$	98

For the three and nine months ended March 31, 2015, we made $20,000 and $74,000, respectively, in contributions to our postretirement medical and life insurance benefit plans. We expect to make approximately $0.1 million more in contributions to our postretirement medical and life insurance benefit plans during the remainder of 2015.

Note 9 – Commitments and Contingencies

At March 31, 2015, we were a party to various claims and litigation matters arising in the ordinary course of business. Such matters did not have a material effect on the current-year results of operations and, in our opinion, their ultimate disposition will not have a material effect on our consolidated financial statements.

Note 10 – Business Segment Information

The following summary of financial information by business segment is consistent with the basis of segmentation and measurement of segment profit or loss presented in our June 30, 2014 consolidated financial statements. The March 31, 2015 identifiable assets by reportable segment are generally consistent with that of June 30, 2014. However, due to the acquisition of Flatout in March 2015, the amount of Specialty Foods assets increased and Corporate assets declined as compared to June 30, 2014. The increase in Specialty Foods assets reflects goodwill and other intangible assets related to the acquisition of Flatout. Corporate assets declined because of a decrease in cash, which is treated as a Corporate asset, due to cash paid for the acquisition of Flatout.

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Net Sales - Specialty Foods	$	263,400		$	241,849		$	826,798		$	782,267
Operating Income
Specialty Foods	$	34,170		$	31,408		$	124,909		$	130,364
Corporate Expenses	(2,962		)	(2,573		)	(8,881		)	(8,913		)
Total	$	31,208		$	28,835		$	116,028		$	121,451

15

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

Our fiscal year begins on July 1 and ends on June 30. Unless otherwise noted, references to “year” pertain to our fiscal year; for example, 2015 refers to fiscal 2015, which is the period from July 1, 2014 to June 30, 2015.

The following discussion should be read in conjunction with our condensed consolidated financial statements and the notes thereto, all included elsewhere in this report. The forward-looking statements in this section and other parts of this report involve risks, uncertainties and other factors, including statements regarding our plans, objectives, goals, strategies, and financial performance. Our actual results could differ materially from the results anticipated in these forward-looking statements due to these factors. For more information, see the section below entitled “Forward-Looking Statements.”

OVERVIEW

Business Overview

Lancaster Colony Corporation is a manufacturer and marketer of specialty food products for the retail and foodservice markets.

We also manufactured and marketed candles for the food, drug and mass markets until that business was sold on January 30, 2014. The financial results of these operations, previously included in our Glassware and Candles segment, are reported as discontinued operations for all periods presented herein.

Our operations are organized into one reportable segment: “Specialty Foods.” The sales of this segment are predominately domestic.

We view this segment as having the potential to achieve future growth in sales and profitability due to attributes such as:

• leading retail market positions in several branded products with a high-quality perception;

• a broad customer base in both retail and foodservice accounts;

• well-regarded culinary expertise among foodservice accounts;

• recognized leadership in foodservice product development;

• experience in integrating complementary business acquisitions; and

• historically strong cash flow generation that supports growth opportunities.

Our goal is to grow both retail and foodservice sales over time by:

• leveraging the strength of our retail brands to increase current product sales;

• introducing new products and expanding into new channels;

• growing our foodservice sales through the strength of our reputation in product development and quality; and

• pursuing acquisitions that meet our strategic criteria.

Consistent with our current acquisition strategy, in March 2015 we acquired all of the issued and outstanding capital stock of Flatout Holdings, Inc. (“Flatout”), a privately owned manufacturer and marketer of flatbread and pizza crusts based in Saline, Michigan. The purchase price was $92.2 million, net of cash acquired. This transaction is discussed in further detail in Note 2.

We have made substantial capital investments to support our existing food operations and future growth opportunities. Based on our current plans and expectations, we believe our capital expenditures for 2015 will total between $18 and $20 million.

16

RESULTS OF CONSOLIDATED OPERATIONS

Net Sales and Gross Margin

	Three Months Ended   March 31,										Nine Months Ended   March 31,
(Dollars in thousands)	2015			2014			Change				2015			2014			Change
Net Sales - Specialty Foods	$	263,400		$	241,849		$	21,551	9	%	$	826,798		$	782,267		$	44,531	6	%
Gross Margin	$	56,625		$	51,908		$	4,717	9	%	$	192,702		$	190,702		$	2,000	1	%
Gross Margin as a Percentage of Net Sales	21.5		%	21.5		%					23.3		%	24.4		%

In March 2015 we acquired Flatout and its results of operations have been included in our condensed consolidated financial statements from the date of acquisition, but such results were not material to our condensed consolidated financial statements.

Net sales for the three and nine months ended March 31, 2015increased 9% and 6%, respectively, and the growth was primarily driven by volume and mix. Retail net sales increased 14% and 6% during the three and nine months ended March 31, 2015, respectively. This year's earlier Easter holiday shifted seasonal retail sales into the third quarter. Third quarter retail sales growth was also attributed to higher sales of certain product lines including New York BRAND^® frozen garlic bread, New York BRAND^® croutons and salad toppings and Olive Garden^® retail dressings. For the nine months ended March 31, 2015, retail sales increased on higher sales of New York BRAND^® frozen garlic bread and Olive Garden^® retail dressings, but were offset in part by increased promotional spending on some retail product offerings and by placement costs for new products. Foodservice net sales improved 4% and 5% for the quarter and year-to-date periods, respectively, primarily due to increased sales to national chain restaurants. The segment's overall sales volume, as measured by pounds shipped, is estimated to have improved by 5% and 4% for the three and nine months ended March 31, 2015, respectively. The impact of a more favorable sales mix was estimated to be 4% and 1% for the three and nine months ended March 31, 2015, respectively. In general, the impacts of pricing for both retail and foodservice were less than 1% of segment net sales for both the three and nine months ended March 31, 2015.

Gross margin percentages were unchanged for the three months ended March 31, 2015 while the year-to-date percentages declined as the benefits from the improved sales volumes were offset by increased operating costs due to capacity constraints in our dressing manufacturing, higher freight expense, and the increased promotional spending on some retail product offerings and placement costs for new products. We estimate that lower ingredient costs beneficially affected the segment's gross margins by less than 1% of net sales for the three and nine months ended March 31, 2015.

Selling, General and Administrative Expenses

	Three Months Ended   March 31,										Nine Months Ended   March 31,
(Dollars in thousands)	2015			2014			Change				2015			2014			Change
SG&A Expenses	$	25,417		$	23,073		$	2,344	10	%	$	76,674		$	69,251		$	7,423	11	%
SG&A Expenses as a Percentage of Net Sales	9.6		%	9.5		%					9.3		%	8.9		%

Consolidated selling, general and administrative expenses increased 10% and 11% for the three and nine months ended March 31, 2015, respectively, and were generally consistent as a percentage of net sales for the third quarter of 2015 and 2014. The third quarter and year-to-date periods include $0.4 million of transaction expenses related to the acquisition of Flatout in March 2015. The year-to-date increase in these costs also reflected higher consumer promotional spending on new products, as well as increased consumer spending on certain branded retail products.

17

Operating Income

The foregoing factors contributed to consolidated operating income totaling $31.2 million and $116.0 million for the three and nine months ended March 31, 2015, respectively. Our operating income can be summarized as follows:

	Three Months Ended   March 31,											Nine Months Ended   March 31,
(Dollars in thousands)	2015			2014			Change					2015			2014			Change
Operating Income
Specialty Foods	$	34,170		$	31,408		$	2,762		9	%	$	124,909		$	130,364		$	(5,455	)	(4	)%
Corporate Expenses	(2,962		)	(2,573		)	(389		)	15	%	(8,881		)	(8,913		)	32			—	%
Total	$	31,208		$	28,835		$	2,373		8	%	$	116,028		$	121,451		$	(5,423	)	(4	)%
Operating Income as a Percentage of Net Sales
Specialty Foods	13.0		%	13.0		%						15.1		%	16.7		%
Total	11.8		%	11.9		%						14.0		%	15.5		%

Looking forward, as we enter the final quarter of our fiscal year, we anticipate continued investment in certain branded retail products and promotional costs to support products introduced since last spring as well as new products expected to be introduced in the fourth quarter. We expect slightly higher freight costs, but we anticipate material costs to be modestly favorable for the fourth quarter; however, this is tempered by the possibility of a sizeable outbreak of Avian influenza within U.S. laying flocks and its unknown impacts on the price of our egg-based ingredients. Finally, although Easter sales will be absent from the upcoming quarter due to the earlier holiday in 2015, we will capture a full quarter of contribution from our recently acquired Flatout^® flatbread business, but this contribution will be lessened by transitional costs expected to be approximately $0.8 million.

Interest Income and Other – Net

Interest income and other was not material in the three and nine months ended March 31, 2015 and 2014 due to the nominal interest rates earned by us on our cash balances and our capital structure.

Income From Continuing Operations Before Income Taxes

As impacted by the factors discussed above, income from continuing operations before income taxes for the three months ended March 31, 2015increased by $2.5 million to $31.1 million from the prior-year total of $28.6 million. Income from continuing operations before income taxes for the nine months ended March 31, 2015 and 2014 was $115.9 million and $121.1 million, respectively. Consistent with our expectations, our effective tax rate was 34.3% for the nine months ended March 31, 2015, as compared to the prior-year rate of 33.9%.

Income From Continuing Operations

Third quarter income from continuing operations for 2015 of $20.4 millionincreased from the preceding year's income from continuing operations for the quarter of $18.9 million, as influenced by the factors noted above. Our weighted average shares outstanding remained fairly consistent for all periods due to the limited levels of share grants and share repurchases. Consequently, and as largely influenced by the increase in income from continuing operations, diluted income per common share from continuing operations increased from $0.69 for the prior year to $0.75 per diluted share for the third quarter of 2015. Year-to-date income from continuing operations of $76.1 milliondecreased from the prior year-to-date total of $80.1 million. Year-to-date income from continuing operations per share was $2.78 per diluted share compared to $2.93 per diluted share for the prior-year period.

Discontinued Operations

There were no discontinued operations in 2015. Loss from discontinued operations, net of tax, totaled $29.3 million and $26.4 million for the three and nine months ended March 31, 2014, respectively. These amounts included an after-tax loss of $29.6 million on the January 2014 sale of our candle manufacturing and marketing operations. Loss from discontinued operations per share for the third quarter of 2014 was $1.07 per diluted share. Year-to-date loss from discontinued operations per share was $0.97 per diluted share for the nine months ended March 31, 2014.

18

Net Income (Loss)

Third quarter net income for 2015 of $20.4 millionincreased from the preceding year’s net loss for the quarter of $10.4 million, as influenced by the factors noted above. Year-to-date net income of $76.1 million was higher than the prior year-to-date total of $53.7 million. Net income per share for the third quarter of 2015 totaled $0.75 per diluted share, as compared to a net loss of $0.38 per diluted share in the prior year. Year-to-date net income per share was $2.78 per diluted share, as compared to $1.96 per diluted share for the prior-year period.

FINANCIAL CONDITION

For the nine months ended March 31, 2015, net cash provided by operating activities totaled $96.6 million, as compared to $98.8 million in the prior-year period. This change was largely influenced by the discontinued operations resulting from the sale of our candle manufacturing and marketing operations, which were sold in January 2014.

Cash used in investing activities for the nine months ended March 31, 2015 was $109.4 million, as compared to cash provided of $16.6 million in the prior year. The cash used in investing activities in the current year reflects $92.2 million paid for the acquisition of Flatout in March 2015, as well as a higher level of capital expenditures in 2015, the majority of this being spent on our processing capacity expansion project at our Horse Cave, Kentucky dressing facility which was essentially complete at December 31, 2014. The prior year cash provided by investing activities reflected the impact of the proceeds received on the January 2014 sale of our candle manufacturing and marketing operations.

Cash used in financing activities for the nine months ended March 31, 2015 of $37.3 milliondecreased slightly from the prior-year total of $37.5 million. This decrease was primarily due to a lower level of share repurchases in the current year, as partially offset by higher dividend payments. At March 31, 2015, 1,420,000 shares remained authorized for future buyback under the existing share repurchase program.

Under our unsecured revolving credit facility (“Facility”), we may borrow up to a maximum of $120 million at any one time. Loans may be used for general corporate purposes. We had no borrowings outstanding under this Facility at March 31, 2015. At March 31, 2015, we had $4.2 million of standby letters of credit outstanding, which reduced the amount available for borrowing on the Facility. The Facility expires in April 2017, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternative base rate defined in the credit agreement, at our option. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Based on the long-term nature of this Facility, when we have outstanding borrowings under this Facility, they will be classified as long-term debt.

The Facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions, and financial covenants relating to interest coverage and leverage. At March 31, 2015, we were in compliance with all applicable provisions and covenants of the Facility, and we exceeded the requirements of the financial covenants by substantial margins.

We currently expect to remain in compliance with the Facility’s covenants for the foreseeable future. However, a default under the Facility could accelerate the repayment of any outstanding indebtedness and limit our access to additional credit available under the Facility. Such an event could require curtailment of cash dividends or share repurchases, reduce or delay beneficial expansion or investment plans, or otherwise impact our ability to meet our obligations when due. At March 31, 2015, we were not aware of any event that would constitute a default under the Facility.

We believe that internally generated funds and our existing balances in cash and equivalents, in addition to our currently available bank credit arrangements, should be adequate to meet our cash requirements through 2015. If we were to borrow outside of our Facility under current market terms, our average interest rate may increase significantly and have an adverse effect on our results of operations.

CONTRACTUAL OBLIGATIONS

We have various contractual obligations that are appropriately recorded as liabilities in our condensed consolidated financial statements. Certain other items, such as purchase obligations, are not recognized as liabilities in our condensed consolidated financial statements. Examples of such purchase obligations are commitments to purchase raw materials or inventory that has not yet been received as of March 31, 2015 and future minimum lease payments for the use of property and equipment under operating lease agreements. Aside from expected changes in raw-material needs due to changes in product demand, there have been no significant changes to the contractual obligations disclosed in our 2014 Annual Report on Form 10-K.

19

CRITICAL ACCOUNTING POLICIES

There have been no changes in critical accounting policies from those disclosed in our 2014 Annual Report on Form 10-K.

RECENTLY ISSUED ACCOUNTING STANDARDS

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (“ASU 14-09”) which creates a comprehensive set of guidelines for the recognition of revenue under the principle: “Recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” The requirements of ASU 14-09 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2016 and will require either retrospective application to each prior period presented or retrospective application with the cumulative effect of initially applying the standard recognized at the date of adoption. We are currently evaluating the impact this ASU will have on our financial position and results of operations.

RECENTLY ADOPTED ACCOUNTING STANDARDS

There were no recently adopted accounting pronouncements that impacted our consolidated financial statements.

FORWARD-LOOKING STATEMENTS

We desire to take advantage of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). This Quarterly Report on Form 10-Q contains various “forward-looking statements” within the meaning of the PSLRA and other applicable securities laws. Such statements can be identified by the use of the forward-looking words “anticipate,” “estimate,” “project,” “believe,” “intend,” “plan,” “expect,” “hope” or similar words. These statements discuss future expectations; contain projections regarding future developments, operations or financial conditions; or state other forward-looking information. Such statements are based upon assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements involve various important risks, uncertainties and other factors that could cause our actual results to differ materially from those expressed in the forward-looking statements. Actual results may differ as a result of factors over which we have no, or limited, control including, without limitation, the specific influences outlined below. Management believes these forward-looking statements to be reasonable; however, one should not place undue reliance on such statements that are based on current expectations. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update such forward-looking statements, except as required by law.

Items which could impact these forward-looking statements include, but are not limited to:

• the ability to successfully integrate the acquisition of Flatout;

• the potential for loss of larger programs or key customer relationships;

• the effect of consolidation of customers within key market channels;

• the success and cost of new product development efforts;

• the lack of market acceptance of new products;

• price and product competition;

• the reaction of customers or consumers to the effect of price increases we may implement;

• the possible occurrence of product recalls or mislabeled product costs;

• changes in demand for our products, which may result from loss of brand reputation or customer goodwill;

• maintenance of competitive position with respect to other manufacturers;

• the extent to which future business acquisitions are completed and acceptably integrated;

• efficiencies in plant operations;

• fluctuations in the cost and availability of raw materials and packaging;

• capacity constraints that may affect our ability to meet demand or may increase our costs;

• dependence on contract manufacturers;

• stability of labor relations;

20

• adverse changes in freight, energy or other costs of producing, distributing or transporting our products;

• the impact of fluctuations in our pension plan asset values on funding levels, contributions required and benefit costs;

• dependence on key personnel;

• changes in financial markets;

• access to any required financing;

• changes in estimates in critical accounting judgments;

• the outcome of any litigation or arbitration; and

• certain other factors, including the information disclosed in our discussion of risk factors under Item 1A of our 2014 Annual Report on Form 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Our market risks have not changed materially from those disclosed in our 2014 Annual Report on Form 10-K.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures. As of the end of the period covered by this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer evaluated, with the participation of management, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March 31, 2015 to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is 1) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and 2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.

(b) Changes in Internal Control Over Financial Reporting. No changes were made to our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

21

PART II – OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed under Item 1A in our 2014 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(c) In November 2010, our Board of Directors approved a share repurchase authorization of 2,000,000 shares, of which 1,420,000 shares remained authorized for future repurchases at March 31, 2015. This share repurchase authorization does not have a stated expiration date. In the third quarter, we made the following repurchases of our common stock:

Period	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans	Maximum Number of Shares that May Yet be Purchased Under the Plans
January 1-31, 2015	—	$	—	—	1,425,949
February 1-28, 2015 (1)	6,267	$	90.76	6,267	1,419,682
March 1-31, 2015	—	$	—	—	1,419,682
Total	6,267	$	90.76	6,267	1,419,682

(1) Represents shares that were repurchased in satisfaction of tax withholding obligations arising from the vesting of restricted stock granted to employees under the Lancaster Colony Corporation 2005 stock plan.

Item 6. Exhibits

See Index to Exhibits following Signatures.

22

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		LANCASTER COLONY CORPORATION
			(Registrant)
Date:	May 7, 2015	By:	/s/ JOHN B. GERLACH, JR.
			John B. Gerlach, Jr.
			Chairman, Chief Executive Officer,
			President and Director
			(Principal Executive Officer)
Date:	May 7, 2015	By:	/s/ DOUGLAS A. FELL
			Douglas A. Fell
			Treasurer, Vice President,
			Assistant Secretary and
			Chief Financial Officer
			(Principal Financial and Accounting Officer)

23

LANCASTER COLONY CORPORATION AND SUBSIDIARIES

FORM 10-Q

MARCH 31, 2015

INDEX TO EXHIBITS

Exhibit Number	Description	Located at
10.1*	Form of Restricted Stock Award Agreement for employees and consultants under the Lancaster Colony Corporation 2005 Stock Plan	Filed herewith
10.2*	Form of Stock Appreciation Rights Award Agreement for employees and consultants under the Lancaster Colony Corporation 2005 Stock Plan	Filed herewith
31.1	Certification of CEO under Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith
31.2	Certification of CFO under Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith
32	Certification of CEO and CFO under Section 906 of the Sarbanes-Oxley Act of 2002	Furnished herewith
101.INS	XBRL Instance Document	Filed herewith
101.SCH	XBRL Taxonomy Extension Schema Document	Filed herewith
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document	Filed herewith
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document	Filed herewith
101.LAB	XBRL Taxonomy Extension Label Linkbase Document	Filed herewith
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document	Filed herewith
*Indicates a management contract or compensatory plan, contract or arrangement in which any Director or any Executive Officer participates.

24

EX-10.1

Exhibit 10.1

LANCASTER COLONY CORPORATION

FORM OF RESTRICTED STOCK AWARD AGREEMENT

This Restricted Stock Award Agreement (this “Agreement”) is dated as of February 24, 2015, by and between Lancaster Colony Corporation, an Ohio corporation (the “Company”), and __________________, a Service Provider for the Company (the “Grantee”).

W I T N E S S E T H

WHEREAS, the Company desires to award Restricted Stock to the Grantee in accordance with the provisions of the Amended and Restated 2005 Stock Plan (the “Plan”); and

WHEREAS, the Grantee wishes to accept such award; and

WHEREAS, the execution of this Agreement has been authorized by a resolution of the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of the Company that was duly adopted on February 24, 2015; and

WHEREAS, the Company hereby confirms to the Grantee the grant, effective on February 24, 2015 (the “Grant Date”), pursuant to the Plan, of _____ shares of Restricted Stock (“Awarded Shares”) subject to the terms and conditions of the Plan and the terms and conditions described below; and

WHEREAS, the parties hereto understand and agree that any terms used and not defined herein have the same meanings as in the Plan.

NOW, THEREFORE, the Company and the Grantee hereby agree as follows:

1.    Provisions of the Plan Controlling. The Grantee specifically understands and agrees that the Awarded Shares are being granted under the Plan, and are being granted to the Grantee as Restricted Stock pursuant to the Plan, copies of which the Grantee acknowledges the Grantee has read and understands and by which the Grantee agrees to be bound. The provisions of the Plan are incorporated herein by reference. In the event of a conflict between the terms and conditions of the Plan and this Agreement, the provisions of the Plan will control.

2.    Vesting of Awarded Shares.

(a)    Except as provided in Section 2(b) and 2(c), the Awarded Shares shall be forfeited to the Company for no consideration in the event the Grantee (i) voluntarily ceases to retain Continuous Status as an Employee or Consultant prior to the third anniversary of the Grant Date or (ii) ceases to retain Continuous Status as an Employee or Consultant as a result of being terminated by the Company, with or without cause, prior to the third anniversary of the Grant Date.

(b)    The Awarded Shares shall be fully vested in the Grantee and no longer subject to a risk of forfeiture pursuant to Section 2(a) upon the occurrence of the earlier of the following events:

(i)    the date on which the Grantee dies or ceases to retain Continuous Status as an Employee or Consultant as a result of the Grantee’s Disability; or

(ii)    the third anniversary of the Grant Date.

(c)    Unless the Board determines otherwise, if Grantee is Retirement Eligible as of the Grant Date:

(i)    one third of the Awarded Shares shall be fully vested in the Grantee and no longer subject to a risk of forfeiture pursuant to Section 2(a) if Grantee Retires after the first anniversary of the Grant Date but before the second anniversary of the Grant Date; and

(ii)    two thirds of the Awarded Shares shall be fully vested in the Grantee and no longer subject to a risk of forfeiture pursuant to Section 2(a) if Grantee Retires after the second anniversary of the Grant Date but before the third anniversary of the Grant Date.

For purposes of this Agreement: “Retire” shall mean, unless the Board determines otherwise, the Grantee’s termination of his or her employment (other than by death or Disability). “Retirement Eligible” shall mean the Grantee has attained the age of 63 and has achieved ten years of Continuous Status as an Employee or Consultant; “Vesting Date” shall mean the earliest of a Change in Control or the events described in Section 2(b) or Section 2(c).

3.    Dividend and Voting Rights.

(a)    Dividends payable with respect to the Awarded Shares during the period prior to the Vesting Date shall be paid to the Grantee in the same manner as paid on the Common Stock of the Company, unless the Grantee forfeits the Awarded Shares pursuant to Section 2(a) hereof, in which case the Grantee shall also forfeit the right to receive any dividends not paid prior to such forfeiture.

(b)    The Grantee shall have the right to vote any Awarded Shares; provided, that such voting rights shall lapse with respect to any Awarded Shares that are forfeited to the Company pursuant to this Agreement.

4.    Additional Shares. If the Company pays a stock dividend or declares a stock split on or with respect to any of its Common Stock, or otherwise distributes securities of the Company to the holders of its Common Stock, the shares of stock or other securities of the Company issued with respect to the Awarded Shares then subject to the restrictions contained in this Agreement shall be held in escrow and shall be distributed to the Grantee on the Vesting Date, unless the Grantee forfeits the Awarded Shares pursuant to Section 2(a) hereof, in which case the Grantee shall also forfeit the right to receive such stock or other securities. If the Company shall distribute to its shareholders shares of stock of another corporation, the shares of stock of such other corporation distributed with respect to the Awarded Shares then subject to the restrictions contained in this Agreement shall be held in escrow and shall be distributed to the Grantee on such Vesting Date, unless the Grantee forfeits the Awarded Shares pursuant to Section 2(a) hereof, in which case the Grantee shall also forfeit the right to receive such stock.

5.    Effect of Change in Control. Notwithstanding anything in this Agreement to the contrary, including Section 2, in the event of a Change in Control, the Awarded Shares will be affected in accordance with Section 15 of the Plan.

6.    Adjustments. The Awarded Shares shall be subject to adjustment in accordance with Section 15 of the Plan.

7.    Legends. To the extent certificates representing the Awarded Shares are issued to the Grantee pursuant to this Agreement, such certificates shall have endorsed thereon legends substantially as follows (or in such other form as counsel for the Company may determine is necessary or appropriate):

“The shares represented by this certificate are subject to restrictions set forth in a Restricted Stock Award Agreement with this Company dated February 24, 2015, a copy of which Agreement is available for inspection at the offices of the Company or will be made available upon request.”

8.    Withholding Taxes. To the extent that the Company is required to withhold federal, state, local or foreign taxes in connection with any delivery of Awarded Shares to the Grantee, and the amounts available to the Company for such withholding are insufficient, it shall be a condition to the receipt of such delivery that the Grantee make arrangements satisfactory to the Company for payment of the balance of such taxes required to be withheld. The Grantee may elect that all or any part of such withholding requirement be satisfied by retention by the Company of a portion of the Awarded Shares to be delivered to the Grantee. If such election is made, the Awarded Shares so retained shall be credited against such withholding requirement at the Fair Market Value of a Share on the date of such delivery, with any fractional Shares that would otherwise be delivered being rounded up to the next nearest whole Share. In no event shall the Fair Market Value of Awarded Shares to be withheld pursuant to this Section 8 to satisfy applicable withholding taxes in connection with the benefit exceed the minimum amount of taxes required to be withheld.

9.    Notices. Any notices required or permitted by the terms of this Agreement or the Plan must be in writing, shall be delivered to the Grantee at his or her address on file with the Company or to the Company addressed as follows (or to such other address or addresses of which notice in the same manner has previously been given), and will be deemed to have been duly given (a) when delivered in person, (b) when dispatched by electronic facsimile transfer (if confirmed in writing by mail simultaneously dispatched), (c) one business day after having been dispatched by a nationally recognized overnight

courier service or (d) three business days after being sent by registered or certified mail, return receipt requested, postage prepaid:

Lancaster Colony Corporation

37 West Broad Street

Columbus, Ohio 43215

Attention: Corporate Secretary

10.    No Employment Contract; Right to Terminate Employment. The grant of the Awarded Shares to the Grantee is a voluntary, discretionary award being made on a one-time basis and it does not constitute a commitment to make any future awards. The grant of the Awarded Shares and any payments made hereunder will not be considered salary or other compensation for purposes of any severance pay or similar allowance, except as otherwise required by law. Nothing in this Agreement will give the Grantee any right to continue employment with the Company or any of its subsidiaries, as the case may be, or interfere in any way with the right of the Company or any of its subsidiaries to terminate the employment of the Grantee at any time.

11.    Relation to Other Benefits. Any economic or other benefit to the Grantee under this Agreement or the Plan shall not be taken into account in determining any benefits to which the Grantee may be entitled under any profit‑sharing, retirement or other benefit or compensation plan maintained by the Company or a subsidiary of the Company and shall not affect the amount of any life insurance coverage available to any beneficiary under any life insurance plan covering employees of the Company or a Subsidiary of the Company.

12.    Protected Information. In consideration of the Awarded shares, the Grantee agrees:

(a)    That all Innovations, as hereinafter defined, shall belong to and be the exclusive property of the Company or any of its subsidiaries (for the purposes of this Section 12, the “Company”). “Innovations” shall mean all discoveries, developments, designs, ideas, innovations, improvements, inventions, formulas, processes, techniques, and know-how (whether or not patentable or registrable under copyright, trademark or similar statutes) made, conceived, reduced to practice or learned by the Grantee either alone or jointly with another while in the employ of the Company, or disclosed to a third party by the Grantee within one (1) year of leaving its employ, that

(i)     relate directly to the Company's business or the production of any character of goods or materials sold or used by the Company,

(ii)    result from tasks assigned to the Grantee by the Company, or

(iii)     result from the use of premises or equipment owned, leased, or otherwise acquired by the Company.

The Grantee will promptly disclose all Innovations to the Company and will assign all of the Grantee’s right, title and interest to such Innovations, whether in the United States and any foreign country, to the Company and its successors and assigns. The Grantee will from time to time, upon request and at the expense of the Company, sign all instruments necessary for the filing and prosecution of any copyrights, patents, mask works, and applications for letters patent of the United States or any foreign country which the Company may desire to file upon such inventions without additional compensation. The Grantee will render all reasonable assistance to the Company and its agents in preparing applications and other documents and do all things that may be reasonable and necessary to protect the rights of the Company and vest in it all such inventions, discoveries, applications, and patents, even if the Grantee is no longer employed by the Company, provided that the Company compensates the Grantee at a reasonable rate for time actually spent by the Grantee on assistance occurring after termination of employment.

(b)    That the Grantee is not subject to any agreement which in any way prohibits the Grantee from rendering any services to the Company for which the Grantee is or has been employed. The Grantee also agrees and understands that while employed by the Company, the Grantee may be working with secret and confidential formulas and processes for food products, as well as other secret, proprietary and confidential information including, but not limited to, customer lists, supplier lists, methods of pricing, marketing and sales strategies, sources of ingredients and financial data (together, the "Confidential Information"). The Grantee recognizes that the Confidential Information is the sole and exclusive property of Company, and the Company depends on the exclusive possession of Confidential Information to maintain a competitive advantage. Accordingly, the Grantee agrees to maintain for all time the confidentiality of the Confidential Information and any confidential information of third parties that the Grantee receives in the course of performing the Grantee’s duties for the Company. The Grantee further agrees not to copy,

use or disclose such information except in the performance of the Grantee’s authorized duties for the Company, unless permitted in writing by the President of the Company to do so.

(c)    That upon termination of employment with the Company for any reason, the Grantee will immediately deliver to the Company all drawings, blueprints, sketches, notebooks, formulae, notes, manuals and other documents reflecting Confidential Information or Innovations, and the Grantee will not retain copies of such information. During and for one year immediately following the termination of Grantee’s employment with the Company for any reason, the Grantee, either on his or her own account or for any other party, will not interfere with the business of the Company in any manner and will not engage in any activity that is designed to, would, or in fact does cause, encourage or entice any supplier, customer, employee or consultant of the Company with whom the Grantee interacted while employed with the Company to end, reduce or breach its business relationship with the Company.

If the Grantee breaches this Section 12 of the Agreement, the Grantee waives any claim or defense that the Company was not irreparably harmed by that breach. The Company shall have the right to injunctive relief to restrain any actual or threatened breach of this Section 12, in addition to all of the remedies otherwise available to the Company, which shall be cumulative. The Grantee has read and understood all of the provisions in this Section 12 and agrees that they are fair and reasonable and are reasonably required for the protection of the interests of the Company. The Grantee agrees to notify any of the Grantee’s actual or prospective employers of the existence and terms of this Agreement and agrees that the Company may notify such employers of the terms of this Agreement as well.

13.    Information.Information about the Grantee and the Grantee’s participation in the Plan may be collected, recorded and held, used and disclosed for any purpose related to the administration of the Plan. The Grantee understands that such processing of this information may need to be carried out by the Company and its subsidiaries and by third party administrators whether such persons are located within the Grantee’s country or elsewhere, including the United States of America. The Grantee consents to the processing of information relating to the Grantee and the Grantee’s participation in the Plan in any one or more of the ways referred to above.

14.    Benefit of Agreement. Subject to the provisions of the Plan and the other provisions hereof, this Agreement is for the benefit of and is binding on the heirs, executors, administrators, successors and assigns of the parties hereto.

15.    Entire Agreement. This Agreement, together with the Plan, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret, change or restrict the express terms and provisions of this Agreement; provided, however, in any event, this Agreement shall be subject to and governed by the Plan. The Board shall have authority, subject to the express provisions of the Plan and this Agreement, to establish, amend and rescind rules and regulations relating to the Plan, and to make all other determinations that are, in the judgment of the Board, necessary or desirable for the administration of the Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in this Agreement in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency. All actions by the Board under the provisions of this Section 15 shall be conclusive for all purposes.

16.    Amendments. Any amendment to the Plan shall be deemed to be an amendment to this Agreement to the extent that the amendment is applicable hereto; provided, however, that no amendment shall adversely affect the rights of the Grantee with respect to the Awarded Shares without the Grantee’s consent.

17.    Severability. It is the intention and agreement of the Company and the Grantee that this Agreement shall be construed in such a manner as to impose only those restrictions on the conduct of the Grantee that are reasonable in light of the circumstances as they then exist and as are necessary to assure the Company of the intended benefit of this Agreement. In the event that one or more of the provisions of this Agreement shall be invalidated for any reason by a court of competent jurisdiction, any provision so invalidated (including, but not limited to, any provision in Section 12 hereof) shall be deemed to be separable from the other provisions hereof, and the remaining provisions hereof shall continue to be valid and fully enforceable.

18.    Governing Law. This Agreement is made under, and shall be construed in accordance with the internal substantive laws of the State of Ohio.

19.    Waivers and Consents. The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.

20.    Electronic Delivery and Consent to Electronic Participation. The Company may, in its sole discretion, decide to deliver any documents related to the Awarded Shares and participation in the Plan or future grants of Restricted Stock that may be granted under the Plan by electronic means. Notwithstanding anything in this Agreement to the contrary, Grantee hereby consents to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company, including the acceptance of Restricted Stock grants and the execution of award agreements through electronic signature.

[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

Executed in the name and on behalf of the Company in Columbus, Ohio as of the 24^th day of February, 2015.

LANCASTER COLONY CORPORATION
By:	Matthew R. Shurte
	Name: Matthew R. Shurte
	Title: General Counsel & Chief Ethics Officer

ACCEPTANCE OF AGREEMENT

Grantee hereby: (a) acknowledges receiving a copy of the Plan, which has either been previously delivered or is provided with this Agreement, and represents that he or she is familiar with and understands all provisions of the Plan and this Agreement; (b) voluntarily and knowingly accepts this Agreement and the Awarded Shares granted to him or her under this Agreement subject to all provisions of the Plan and this Agreement; and (c) represents that he or she understands that the acceptance of this Agreement through an on-line or electronic system, if applicable, carries the same legal significance as if he or she manually signed the Agreement. Grantee further acknowledges receiving a copy of the Company’s most recent annual report to shareholders and other communications routinely distributed to the Company’s shareholders and a copy of the prospectus pertaining to the Plan.

EX-10.2

Exhibit 10.2

LANCASTER COLONY CORPORATION

FORM OF STOCK APPRECIATION RIGHTS AGREEMENT

This Stock Appreciation Rights Agreement (this “Agreement”) is dated as of February 24, 2015, by and between Lancaster Colony Corporation, an Ohio corporation (the “Company”), and __________________, a Service Provider for the Company (the “Grantee”).

W I T N E S S E T H

WHEREAS, the Company desires to award free-standing Stock Appreciation Rights to the Grantee in accordance with the provisions of the Amended and Restated 2005 Stock Plan (the “Plan”); and

WHEREAS, the Grantee wishes to accept such award; and

WHEREAS, the execution of this Agreement has been authorized by a resolution of the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of the Company that was duly adopted on February 24, 2015; and

WHEREAS, the Company hereby confirms to the Grantee the grant, effective on February 24, 2015 (the “Grant Date”), pursuant to the Plan, of _______ free-standing Stock Appreciation Rights (“SARs”) subject to the terms and conditions of the Plan and the terms and conditions described below, which SARs are a right to receive Shares with a Fair Market Value equal to 100% of the Spread at the time of exercise; and

WHEREAS, the parties hereto understand and agree that any terms used and not defined herein have the same meanings as in the Plan.

NOW, THEREFORE, the Company and the Grantee hereby agree as follows:

1. Definitions. As used in this Agreement:

(a)“Base Price” means $_____, which is not less than the Fair Market Value of a Share on the Grant Date.

(b)“Spread” means the excess of the Fair Market Value of a Share on the date on which a SAR is exercised over the Base Price.

2.Vesting of SARs. The SARs shall become exercisable as follows:

(a)one-third of the SARs shall become exercisable on the first anniversary of the Grant Date if the Grantee shall have retained Continuous Status as an Employee or Consultant through such date;

(b)an additional one-third of the SARs shall become exercisable on the second anniversary of the Grant Date if the Grantee shall have retained Continuous Status as an Employee or Consultant through such date;

(c)the remaining one-third of the SARs shall become exercisable on the third anniversary of the Grant Date if the Grantee shall have retained Continuous Status as an Employee or Consultant through such date;

provided, that notwithstanding anything in this Section 2 to the contrary, if Grantee is Retirement Eligible as of the Grant Date, any SARs that have not become exercisable prior to the date of Grantee’s Retirement shall become exercisable, subject to Section 4, in accordance with the schedule set forth in clauses (a), (b) and (c) of this Section 2 but without regard to whether Grantee has retained Continuous Status as an Employee or Consultant. In calculating the one-third amounts described in Sections 2(a), (b) and (c), fractional SARs shall be rounded down to the nearest whole SAR for each of the first two anniversaries of the Grant Date, and the remaining SARs shall be included with those SARs that become exercisable on the third anniversary of the Grant Date. To the extent exercisable, the SARs may be exercised from time to time in accordance with the Plan and this Agreement. To the extent the SARs or any portion thereof do not become exercisable as provided in this

Section 2, such unexercisable SARs or portion thereof shall be forfeited to the Company for no consideration. For purposes of this Agreement: “Retirement” shall mean, unless the Board determines otherwise, the Grantee’s termination of his or her employment (other than by death or Disability) at least six months after the Grant Date. “Retirement Eligible” shall mean the Grantee has attained the age of 63 and has achieved ten years of Continuous Status as an Employee or Consultant.

3. Exercise of SARs.

(a)To the extent exercisable as provided in Section 2 or Section 5 of this Agreement, the SARs may be exercised in whole or in part by delivery to the Company of a statement in form and substance satisfactory to the Committee specifying the number of SARs to be exercised.

(b)Upon exercise, the Company will issue to the Grantee the number of Shares equal to the quotient of (i) the product of (A) the Spread multiplied by (B) the number of SARs exercised divided by (ii) the Fair Market Value of a Share on the date of exercise, with such quotient rounded down to the nearest whole Share.

4.Termination of SARs. The SARs shall terminate upon the earliest to occur of the following:

(a)90 days after the Grantee ceases to retain Continuous Status as an Employee or Consultant other than upon the Grantee’s death or Disability or Retirement;

(b)180 days after the Grantee ceases to retain Continuous Status as an Employee or Consultant as a result of the Grantee’s Disability;

(c)One year after the Grantee ceases to retain Continuous Status as an Employee or Consultant as a result of the Grantee’s death; and

(d)Five years from the Grant Date.

5.Effect of Change in Control. Notwithstanding anything in this Agreement to the contrary, including Section 2, in the event of a Change in Control, the SARs will be affected in accordance with Section 15 of the Plan.

6.Transferability. No SAR may be transferred by the Grantee other than by will or the laws of descent and distribution. The SARs may be exercised during a Grantee’s lifetime only by the Grantee or, in the event of the Grantee legal incapacity, by the Grantee’s guardian or legal representative acting in a fiduciary capacity on behalf of the Grantee under state law and court supervision. The SARs may be exercised after the Grantee’s death by (a) the Grantee’s designated beneficiary, provided such beneficiary has been designated prior to the Grantee’s death in a form acceptable to the Committee, or (b) the personal representative of the Grantee’s estate or by the person(s) to whom the SARs are transferred pursuant to the Grantee’s will or in accordance with the laws of descent and distribution.

7.Compliance with Law. The SARs shall not be exercisable if such exercise would involve a violation of any applicable federal or state securities law, and the Company hereby agrees to make reasonable efforts to comply with any applicable federal and state securities law.

8.Adjustments. The SARs shall be subject to adjustment in accordance with Section 15 of the Plan.

9.Withholding Taxes. To the extent that the Company is required to withhold federal, state, local or foreign taxes in connection with the exercise of the SARs, and the amounts available to the Company for such withholding are insufficient, it shall be a condition to such exercise that the Grantee make arrangements satisfactory to the Company for payment of the balance of such taxes required to be withheld. The Grantee may elect that all or any part of such withholding requirement be satisfied by retention by the Company of a portion of the Shares to be delivered to the Grantee. If such election is made, the Shares so retained shall be credited against such withholding requirement at the Fair Market Value of a Share on the date of such delivery, with any fractional Shares that would otherwise be delivered being rounded up to the next nearest whole Share. In no event shall the Fair Market Value of Shares to be withheld pursuant to this Section 9 to satisfy applicable withholding taxes in connection with the benefit exceed the minimum amount of taxes required to be withheld.

10.Notices. Any notices required or permitted by the terms of this Agreement or the Plan must be in writing, shall be delivered to the Grantee at his or her address on file with the Company or to the Company addressed as follows (or to such other address or addresses of which notice in the same manner has previously been given), and will be deemed to have been duly given (a) when delivered in person, (b) when dispatched by electronic facsimile transfer (if confirmed in writing by

mail simultaneously dispatched), (c) one business day after having been dispatched by a nationally recognized overnight courier service or (d) three business days after being sent by registered or certified mail, return receipt requested, postage prepaid:

Lancaster Colony Corporation

37 West Broad Street

Columbus, Ohio 43215

Attention: Corporate Secretary

11.No Employment Contract; Right to Terminate Employment. The grant of SARs to the Grantee is a voluntary, discretionary award being made on a one-time basis and it does not constitute a commitment to make any future awards. The grant of the SARs and any payments made hereunder will not be considered salary or other compensation for purposes of any severance pay or similar allowance, except as otherwise required by law. Nothing in this Agreement will give the Grantee any right to continue employment with the Company or any Subsidiary, as the case may be, or interfere in any way with the right of the Company or a Subsidiary to terminate the employment of the Grantee at any time.

12.Relation to Other Benefits. Any economic or other benefit to the Grantee under this Agreement or the Plan shall not be taken into account in determining any benefits to which the Grantee may be entitled under any profit‑sharing, retirement or other benefit or compensation plan maintained by the Company or a Subsidiary and shall not affect the amount of any life insurance coverage available to any beneficiary under any life insurance plan covering employees of the Company or a Subsidiary.

13.Protected Information. In consideration of the Awarded shares, the Grantee agrees:

(a)    That all Innovations, as hereinafter defined, shall belong to and be the exclusive property of the Company or any of its subsidiaries (for the purposes of this Section 13, the “Company”). “Innovations” shall mean all discoveries, developments, designs, ideas, innovations, improvements, inventions, formulas, processes, techniques, and know-how (whether or not patentable or registrable under copyright, trademark or similar statutes) made, conceived, reduced to practice or learned by the Grantee either alone or jointly with another while in the employ of the Company, or disclosed to a third party by the Grantee within one (1) year of leaving its employ, that

(i)     relate directly to the Company's business or the production of any character of goods or materials sold or used by the Company,

(ii)    result from tasks assigned to the Grantee by the Company, or

(iii)     result from the use of premises or equipment owned, leased, or otherwise acquired by the Company.

The Grantee will promptly disclose all Innovations to the Company and will assign all of the Grantee’s right, title and interest to such Innovations, whether in the United States and any foreign country, to the Company and its successors and assigns. The Grantee will from time to time, upon request and at the expense of the Company, sign all instruments necessary for the filing and prosecution of any copyrights, patents, mask works, and applications for letters patent of the United States or any foreign country which the Company may desire to file upon such inventions without additional compensation. The Grantee will render all reasonable assistance to the Company and its agents in preparing applications and other documents and do all things that may be reasonable and necessary to protect the rights of the Company and vest in it all such inventions, discoveries, applications, and patents, even if the Grantee is no longer employed by the Company, provided that the Company compensates the Grantee at a reasonable rate for time actually spent by the Grantee on assistance occurring after termination of employment.

(b)    That the Grantee is not subject to any agreement which in any way prohibits the Grantee from rendering any services to the Company for which the Grantee is or has been employed. The Grantee also agrees and understands that while employed by the Company, the Grantee may be working with secret and confidential formulas and processes for food products, as well as other secret, proprietary and confidential information including, but not limited to, customer lists, supplier lists, methods of pricing, marketing and sales strategies, sources of ingredients and financial data (together, the "Confidential Information"). The Grantee recognizes that the Confidential Information is the sole and exclusive property of Company, and the Company depends on the exclusive possession of Confidential Information to maintain a competitive advantage. Accordingly, the Grantee agrees to maintain for all time the confidentiality of the Confidential Information and any confidential information of third parties that the Grantee

receives in the course of performing the Grantee’s duties for the Company. The Grantee further agrees not to copy, use or disclose such information except in the performance of the Grantee’s authorized duties for the Company, unless permitted in writing by the President of the Company to do so.

(c)    That upon termination of employment with the Company for any reason, the Grantee will immediately deliver to the Company all drawings, blueprints, sketches, notebooks, formulae, notes, manuals and other documents reflecting Confidential Information or Innovations, and the Grantee will not retain copies of such information. During and for one year immediately following the termination of Grantee’s employment with the Company for any reason, the Grantee, either on his or her own account or for any other party, will not interfere with the business of the Company in any manner and will not engage in any activity that is designed to, would, or in fact does cause, encourage or entice any supplier, customer, employee or consultant of the Company with whom the Grantee interacted while employed with the Company to end, reduce or breach its business relationship with the Company.

If the Grantee breaches this Section 13 of the Agreement, the Grantee waives any claim or defense that the Company was not irreparably harmed by that breach. The Company shall have the right to injunctive relief to restrain any actual or threatened breach of this Section 13, in addition to all of the remedies otherwise available to the Company, which shall be cumulative. The Grantee has read and understood all of the provisions in this Section 13 and agrees that they are fair and reasonable and are reasonably required for the protection of the interests of the Company. The Grantee agrees to notify any of the Grantee’s actual or prospective employers of the existence and terms of this Agreement and agrees that the Company may notify such employers of the terms of this Agreement as well.

14.Information.Information about the Grantee and the Grantee’s participation in the Plan may be collected, recorded and held, used and disclosed for any purpose related to the administration of the Plan. The Grantee understands that such processing of this information may need to be carried out by the Company and its Subsidiaries and by third party administrators whether such persons are located within the Grantee’s country or elsewhere, including the United States of America. The Grantee consents to the processing of information relating to the Grantee and the Grantee’s participation in the Plan in any one or more of the ways referred to above.

15.Amendments. Any amendment to the Plan shall be deemed to be an amendment to this Agreement to the extent that the amendment is applicable hereto; provided, however, that no amendment shall adversely affect the rights of the Grantee with respect to the SARs without the Grantee’s consent.

16.Severability. In the event that one or more of the provisions of this Agreement shall be invalidated for any reason by a court of competent jurisdiction, any provision so invalidated shall be deemed to be separable from the other provisions hereof, and the remaining provisions hereof shall continue to be valid and fully enforceable.

17.Governing Law. This Agreement is made under, and shall be construed in accordance with the internal substantive laws of the State of Ohio.

18.Provisions of the Plan Controlling. The Grantee specifically understands and agrees that the SARs are being granted under the Plan, copies of which Plan the Grantee acknowledges the Grantee has read, understands and by which the Grantee agrees to be bound. The provisions of the Plan are incorporated herein by reference. In the event of a conflict between the terms and conditions of the Plan and this Agreement, the provisions of the Plan will control. The Board shall have authority, subject to the express provisions of the Plan and this Agreement, to establish, amend and rescind rules and regulations relating to the Plan, and to make all other determinations that are, in the judgment of the Board, necessary or desirable for the administration of the Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in this Agreement in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency. All actions by the Board under the provisions of this Section 18 shall be conclusive for all purposes.

19.    Electronic Delivery and Consent to Electronic Participation. The Company may, in its sole discretion, decide to deliver any documents related to the SARs and participation in the Plan or future grants of Stock Appreciation Rights that may be granted under the Plan by electronic means. Notwithstanding anything in this Agreement to the contrary, Grantee hereby consents to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company, including the acceptance of Stock Appreciation Rights grants and the execution of award agreements through electronic signature.

[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

Executed in the name and on behalf of the Company in Columbus, Ohio as of the 24^th day of February, 2015.

LANCASTER COLONY CORPORATION
By:	Matthew R. Shurte
	Name: Matthew R. Shurte
	Title: General Counsel & Chief Ethics Officer

ACCEPTANCE OF AGREEMENT

Grantee hereby: (a) acknowledges receiving a copy of the Plan, which has either been previously delivered or is provided with this agreement, and represents that he or she is familiar with and understands all provisions of the Plan and this Agreement; (b) voluntarily and knowingly accepts this Agreement and the SARs granted to him or her under this Agreement subject to all provisions of the Plan and this Agreement; and (c) represents that he or she understands that the acceptance of this Agreement through an on-line or electronic system, if applicable, carries the same legal significance as if he or she manually signed the Agreement. Grantee further acknowledges receiving a copy of the Company’s most recent annual report to shareholders and other communications routinely distributed to the Company’s shareholders and a copy of the prospectus pertaining to the Plan.

EX-31.1

Exhibit 31.1

Certification by Chief Executive Officer

I, John B. Gerlach, Jr., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lancaster Colony Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 7, 2015	By:	/s/ JOHN B. GERLACH, JR.
			John B. Gerlach, Jr. Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification by Chief Financial Officer

I, Douglas A. Fell, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lancaster Colony Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 7, 2015	By:	/s/ DOUGLAS A. FELL
			Douglas A. Fell
			Chief Financial Officer

EX-32

Exhibit 32

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18, UNITED STATES CODE, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Lancaster Colony Corporation (the “Company”) on Form 10-Q for the quarter ending March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), John B. Gerlach, Jr., Chief Executive Officer of the Company, and Douglas A. Fell, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ JOHN B. GERLACH, JR.
	John B. Gerlach, Jr.
	Chief Executive Officer
May 7, 2015
By:	/s/ DOUGLAS A. FELL
	Douglas A. Fell
	Chief Financial Officer
May 7, 2015

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

XML

Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Grant Details) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
SSSARs granted (in rights)	149	146
Weighted average grant date fair value per award (usd per share)	$ 9.94	$ 11.84
Weighted average assumptions used in fair value calculations:
Risk-free interest rate	0.86%	0.75%
Dividend yield	2.02%	1.97%
Volatility factor of the expected market price of our common stock	19.62%	22.35%
Weighted average expected life in years	2 years 8 months 16 days	3 years 1 month 13 days

XML

Pension Benefits (Narrative) (Details) (Pension Benefits [Member], USD $)	3 Months Ended	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2015
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer contributions	$ 0	$ 0
Estimated future employer contributions in current fiscal year		$ 0

XML

Stock-Based Compensation (Fair Value Of Restricted Stock Vested) (Details) (Restricted Stock [Member], USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested shares	$ 1,818	$ 877

XML

Goodwill And Other Intangible Assets (Summary Of Other Intangible Assets) (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Jun. 30, 2014
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Total net carrying value	$ 51,696	$ 5,376
Trademarks (40-year life) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying value	370	370
Accumulated amortization	(221)	(214)
Net carrying value	149	156
Finite-lived other intangible assets useful life	40 years
Customer Relationships (10 to 15-year life) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying value	18,020	13,020
Accumulated amortization	(8,531)	(7,800)
Net carrying value	9,489	5,220
Technology / Know-how (10-year life) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying value	3,900	0
Accumulated amortization	(32)	0
Net carrying value	3,868	0
Finite-lived other intangible assets useful life	10 years
Non-compete Agreements (5-year life) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying value	600	0
Accumulated amortization	(10)	0
Net carrying value	590	0
Finite-lived other intangible assets useful life	5 years
Minimum [Member] | Customer Relationships (10 to 15-year life) [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived other intangible assets useful life	10 years
Maximum [Member] | Customer Relationships (10 to 15-year life) [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived other intangible assets useful life	15 years
Tradename (indefinite life) [Member]
Indefinite-lived Intangible Assets [Line Items]
Gross carrying value	$ 37,600	$ 0

XML

Summary Of Significant Accounting Policies (Narrative) (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Jun. 30, 2014
Accounting Policies [Abstract]
Accrued distribution	$ 6.1	$ 6.4

XML

Postretirement Benefits (Narrative) (Details) (Postretirement Benefits [Member], USD $)	3 Months Ended	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2015
Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer contributions	$ 20,000	$ 74,000
Estimated future employer contributions in current fiscal year		$ 100,000

XML

Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock Settled Stock Appreciation Rights SARS [Member]
Number of Rights
Number of Rights, Outstanding at beginning of year (rights)	358
Number of Rights, Exercised (rights)	(54)
Number of Rights, Granted (rights)	149	146
Number of Rights, Forfeited (rights)	(31)
Number of Rights, Outstanding at end of period (rights)	422
Number of Rights, Exercisable and vested at end of period (rights)	154
Number of Rights, Vested and expected to vest at end of period (rights)	412
Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding at beginning of year (usd per share)	$ 76.75
Weighted Average Exercise Price, Exercised (usd per share)	$ 63.54
Weighted Average Exercise Price, Granted (usd per share)	$ 91.13
Weighted Average Exercise Price, Forfeited (usd per share)	$ 79.42
Weighted Average Exercise Price, Outstanding at end of period (usd per share)	$ 83.35
Weighted Average Exercise Price, Exercisable and vested at end of period (usd per share)	$ 74.70
Weighted Average Exercise Price, Vested and expected to vest at end of period (usd per share)	$ 83.35
Weighted Average Remaining Contractual Life in Years, Outstanding at end of period	3 years 8 months 23 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of period	2 years 7 months 28 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of period	3 years 8 months 23 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 4,984
Aggregate Intrinsic Value, Exercisable and vested at end of period	3,150
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 4,873

XML

Income Taxes (Details) (USD $)	Mar. 31, 2015	Jun. 30, 2014
Income Tax Disclosure [Abstract]
Prepaid taxes	$ 10,300,000	$ 9,700,000
Gross tax contingency reserve	1,000,000
Accrued tax liabilities included in the gross tax contingency reserve	600,000
Accrued interest and penalties included in the gross tax contingency reserve	400,000
Gross tax contingency reserve, classified as current liabilities	0
Gross tax contingency reserve, classified as noncurrent liabilities	$ 1,000,000

XML

Business Segment Information (Summary Of Financial Information Attributable To Reportable Segments) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Segment Reporting Information [Line Items]
Net Sales	$ 263,400	$ 241,849	$ 826,798	$ 782,267
Operating Income	31,208	28,835	116,028	121,451
Specialty Foods [Member]
Segment Reporting Information [Line Items]
Net Sales	263,400	241,849	826,798	782,267
Operating Income	34,170	31,408	124,909	130,364
Corporate [Member]
Segment Reporting Information [Line Items]
Operating Income	$ (2,962)	$ (2,573)	$ (8,881)	$ (8,913)

XML

Stock-Based Compensation (Restricted Stock Activity) (Details) (Restricted Stock [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2015
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of Shares, Unvested restricted stock at beginning of year (shares)	58
Number of Shares, Granted (shares)	16
Number of Shares, Vested (shares)	(25)
Number of Shares, Forfeited (shares)	(3)
Number of Shares, Unvested restricted stock at end of period (shares)	46
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value, Unvested restricted stock at beginning of year (usd per share)	$ 79.09
Weighted Average Grant Date Fair Value, Granted (usd per share)	$ 91.89
Weighted Average Grant Date Fair Value, Vested (usd per share)	$ 71.86
Weighted Average Grant Date Fair Value, Forfeited (usd per share)	$ 79.22
Weighted Average Grant Date Fair Value, Unvested restricted stock at end of period (usd per share)	$ 87.61

XML

Goodwill And Other Intangible Assets

9 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill And Other Intangible Assets

Goodwill and Other Intangible Assets

Goodwill attributable to the Specialty Foods segment was $126.7 million and $89.8 million at March 31, 2015 and June 30, 2014, respectively. The increase in goodwill is the result of the acquisition of Flatout on March 13, 2015. See further discussion in Note 2.

The following table is a rollforward of goodwill from June 30, 2014 to March 31, 2015:

	Carrying Value
Goodwill at beginning of year	$	89,840
Goodwill acquired during the period	36,883
Goodwill at end of period	$	126,723

The following table summarizes our identifiable other intangible assets, all included in the Specialty Foods segment. The intangible asset values and lives related to the Flatout acquisition, which are included in the table below, are preliminary and subject to further review over the measurement period. See further discussion in Note 2.

	March 31,   2015			June 30,   2014
Tradename (indefinite life)
Gross carrying value	$	37,600		$	—
Trademarks (40-year life)
Gross carrying value	$	370		$	370
Accumulated amortization	(221		)	(214		)
Net carrying value	$	149		$	156
Customer Relationships (10 to 15-year life)
Gross carrying value	$	18,020		$	13,020
Accumulated amortization	(8,531		)	(7,800		)
Net carrying value	$	9,489		$	5,220
Technology / Know-how (10-year life)
Gross carrying value	$	3,900		$	—
Accumulated amortization	(32		)	—
Net carrying value	$	3,868		$	—
Non-compete Agreements (5-year life)
Gross carrying value	$	600		$	—
Accumulated amortization	(10		)	—
Net carrying value	$	590		$	—
Total net carrying value	$	51,696		$	5,376

Amortization expense for our other intangible assets was as follows:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Amortization expense	$	308	$	236	$	780	$	709

Total annual amortization expense for each of the next five years is estimated to be as follows:

2016	$	1,785
2017	$	1,614
2018	$	1,614
2019	$	1,614
2020	$	1,574

XML

Stock-Based Compensation (Employee Restricted Stock Grant Details) (Details) (Employee Restricted Stock [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Employee Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)	9	24
Grant date fair value	$ 845	$ 2,190
Weighted average grant date fair value per award (usd per share)	$ 91.13	$ 89.21

XML

Acquisition (Narrative) (Details) (USD $)	9 Months Ended		0 Months Ended	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 13, 2015	Mar. 31, 2015
Business Acquisition [Line Items]
Purchase price, net of cash acquired	$ 92,217,000	$ 0
Flatout [Member]
Business Acquisition [Line Items]
Purchase price, net of cash acquired			92,200,000
Purchase price adjustment for the estimate of the final net working capital				200,000
Flatout [Member] | Customer Relationships [Member]
Business Acquisition [Line Items]
Finite-lived intangible assets acquired			5,000,000
Finite-lived intangible assets acquired, useful life			10 years
Flatout [Member] | Technology / Know-how [Member]
Business Acquisition [Line Items]
Finite-lived intangible assets acquired			3,900,000
Finite-lived intangible assets acquired, useful life			10 years
Flatout [Member] | Non-compete Agreements [Member]
Business Acquisition [Line Items]
Finite-lived intangible assets acquired			600,000
Finite-lived intangible assets acquired, useful life			5 years
Flatout [Member] | Tradename [Member]
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired			$ 37,600,000

XML

Summary Of Significant Accounting Policies (Schedule Of Amounts Reclassified Out Of Accumulated Other Comprehensive Loss) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended				9 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Mar. 31, 2015		Mar. 31, 2014
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Accumulated other comprehensive loss at beginning of period	$ (7,936)		$ (8,256)		$ (8,061)		$ (8,391)
Total other comprehensive income, before tax	99		108		297		322
Total tax expense	(37)		(40)		(110)		(119)
Other comprehensive income, net of tax	62		68		187		203
Accumulated other comprehensive loss at end of period	(7,874)		(8,188)		(7,874)		(8,188)
Pension Benefits [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amortization of unrecognized net (gain) loss	107	[1]	115	[1]	321	[1]	345	[1]
Postretirement Benefits [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amortization of unrecognized net (gain) loss	(7)	[1]	(6)	[1]	(21)	[1]	(20)	[1]
Amortization of prior service asset	$ (1)	[1]	$ (1)	[1]	$ (3)	[1]	$ (3)	[1]

[1] Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

XML

Stock-Based Compensation (Nonemployee Director Restricted Stock Grant Details) (Details) (Director Restricted Stock [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Director Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)	7	6
Grant date fair value	$ 639	$ 490
Weighted average grant date fair value per award (usd per share)	$ 92.92	$ 84.42

XML

Acquisition (Schedule Of Purchase Price Allocation) (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Jun. 30, 2014	Mar. 13, 2015
Business Acquisition [Line Items]
Goodwill	$ 126,723	$ 89,840
Flatout [Member]
Business Acquisition [Line Items]
Receivables			2,532
Inventories			3,748
Other current assets			512
Property, plant and equipment			7,198
Goodwill			36,883
Other intangible assets			47,100
Current liabilities			(2,310)
Deferred tax liabilities			(3,225)
Net assets acquired			$ 92,438

XML

Goodwill And Other Intangible Assets (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 126,723	$ 89,840

XML

Acquisition

9 Months Ended

Mar. 31, 2015

Business Combinations [Abstract]

Acquisition

Acquisition

On March 13, 2015, we acquired all of the issued and outstanding capital stock of Flatout Holdings, Inc. (“Flatout”), a privately owned manufacturer and marketer of flatbread and pizza crusts based in Saline, Michigan. The purchase price, net of cash acquired, was $92.2 million and was funded by cash on hand. The purchase price is subject to the finalization of cash and net working capital adjustments. Flatout is reported in our Specialty Foods segment, and its results of operations have been included in our condensed consolidated financial statements from the date of acquisition, but such results were not material to our condensed consolidated financial statements.

The following preliminary purchase price allocation is based on the estimated fair value of the net assets acquired, as adjusted for the estimate of the final net working capital of $0.2 million recorded as of March 31:

Balance Sheet Captions	Allocation
Receivables	$	2,532
Inventories	3,748
Other current assets	512
Property, plant and equipment	7,198
Goodwill (not tax deductible)	36,883
Other intangible assets	47,100
Current liabilities	(2,310		)
Deferred tax liabilities	(3,225		)
Net assets acquired	$	92,438

Further adjustments are expected to the allocation above as the third-party valuation is finalized and certain tax aspects of the transaction and a customary post-closing review are completed during the measurement period.

The goodwill recognized above arose because the purchase price for Flatout reflects a number of factors including the future earnings and cash flow potential of Flatout and the avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance our existing product offerings and enter the supermarket deli department. Goodwill also results from the workforce acquired with Flatout.

We have determined the preliminary values and lives of the other intangible assets listed in the allocation above as: $37.6 million for the tradename with an indefinite life; $5.0 million for the customer relationships with a 10-year life; $3.9 million for the technology / know-how with a 10-year life and $0.6 million for the non-compete agreements with a 5-year life. We will continue to evaluate these values and lives during the measurement period.

Pro forma results of operations have not been presented herein as the acquisition was not considered material to our results of operations.

XML

Goodwill And Other Intangible Assets (Rollforward Of Goodwill) (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2015
Goodwill [Roll Forward]
Carrying Value, Goodwill at beginning of year	$ 89,840
Carrying Value, Goodwill acquired during the period	36,883
Carrying Value, Goodwill at end of period	$ 126,723

XML

Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Compensation Expense And Tax Benefits Recorded) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Excess tax benefits			$ 456	$ 927
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	308	304	893	804
Tax benefits	108	106	313	281
Intrinsic value of exercises	207	2,343	863	2,431
Excess tax benefits	$ 72	$ 820	$ 302	$ 851

XML

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Jun. 30, 2014
Current Assets:
Cash and equivalents	$ 161,417	$ 211,539
Receivables (less allowance for doubtful accounts, March-$194; June-$432)	69,374	57,808
Inventories:
Raw materials	29,951	28,069
Finished goods	42,319	46,447
Total inventories	72,270	74,516
Deferred income taxes and other current assets	26,128	23,428
Total current assets	329,189	367,291
Property, Plant and Equipment:
Land, buildings and improvements	112,836	107,690
Machinery and equipment	253,537	238,791
Total cost	366,373	346,481
Less accumulated depreciation	190,878	177,807
Property, plant and equipment-net	175,495	168,674
Other Assets:
Goodwill	126,723	89,840
Other intangible assets-net	51,696	5,376
Other noncurrent assets	8,127	7,449
Total	691,230	638,630
Current Liabilities:
Accounts payable	43,796	37,907
Accrued liabilities	33,226	31,165
Total current liabilities	77,022	69,072
Other Noncurrent Liabilities	20,868	22,208
Deferred Income Taxes	23,969	18,753
Commitments and Contingencies
Shareholders' Equity:
Preferred stock-authorized 3,050,000 shares; outstanding-none
Common stock-authorized 75,000,000 shares; outstanding – March-27,356,804 shares; June-27,339,421 shares	107,020	104,789
Retained earnings	1,206,136	1,167,211
Accumulated other comprehensive loss	(7,874)	(8,061)
Common stock in treasury, at cost	(735,911)	(735,342)
Total shareholders' equity	569,371	528,597
Total	$ 691,230	$ 638,630

XML

Stock-Based Compensation (Restricted Stock Compensation Expense And Tax Benefits Recorded) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Excess tax benefits			$ 456	$ 927
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	384	366	1,318	1,027
Tax benefits	134	128	461	359
Excess tax benefits	$ 142	$ 68	$ 154	$ 76

XML

Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash Flows From Operating Activities:
Net income	$ 76,118	$ 53,659
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	14,937	15,596
Deferred income taxes and other noncash changes	2,527	5,144
Stock-based compensation expense	2,211	1,777
Excess tax benefit from stock-based compensation	(456)	(927)
Gain on sale of property	0	(6)
Loss on sale of discontinued operations	0	44,027
Pension plan activity	(444)	(182)
Changes in operating assets and liabilities:
Receivables	(8,981)	(10,813)
Inventories	5,996	7,901
Other current assets	(1,853)	(13,602)
Accounts payable and accrued liabilities	6,508	(3,779)
Net cash provided by operating activities	96,563	98,795
Cash Flows From Investing Activities:
Cash paid for acquisition, net of cash acquired	(92,217)	0
Payments on property additions	(15,752)	(8,143)
Proceeds from sale of property	0	6
Proceeds from sale of discontinued operations	0	25,616
Other-net	(1,410)	(854)
Net cash (used in) provided by investing activities	(109,379)	16,625
Cash Flows From Financing Activities:
Purchase of treasury stock	(569)	(3,120)
Payment of dividends	(37,193)	(34,960)
Excess tax benefit from stock-based compensation	456	927
Decrease in cash overdraft balance	0	(324)
Net cash used in financing activities	(37,306)	(37,477)
Net change in cash and equivalents	(50,122)	77,943
Cash and equivalents at beginning of year	211,539	123,385
Cash and equivalents at end of period	161,417	201,328
Supplemental Disclosure of Operating Cash Flows:
Cash paid during the period for income taxes	$ 37,835	$ 36,941

XML

Goodwill And Other Intangible Assets (Estimated Annual Amortization Expense) (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
2016	$ 1,785
2017	1,614
2018	1,614
2019	1,614
2020	$ 1,574

XML

Pension Benefits (Tables) (Pension Benefits [Member])

9 Months Ended

Mar. 31, 2015

Pension Benefits [Member]

Defined Benefit Plan Disclosure [Line Items]

Components Of Net Periodic Benefit Income

The following table summarizes the components of net periodic benefit income for our pension plans:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Components of net periodic benefit income
Interest cost	$	403		$	439		$	1,209		$	1,315
Expected return on plan assets	(658		)	(614		)	(1,974		)	(1,842		)
Amortization of unrecognized net loss	107			115			321			345
Net periodic benefit income	$	(148	)	$	(60	)	$	(444	)	$	(182	)

XML

Long-Term Debt (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014
Debt Disclosure [Abstract]
Maximum borrowing capacity	$ 120,000,000		$ 120,000,000		$ 120,000,000
Maximum borrowing capacity on obtaining consent of the issuing bank	200,000,000		200,000,000		200,000,000
Line of credit facility, expiration date			Apr. 18, 2017
Line of credit facility, amount outstanding	0		0		0
Standby letters of credit, amount outstanding	4,200,000		4,200,000
Interest paid	$ 0	$ 0	$ 0	$ 0
Minimum interest coverage ratio			250.00%
Maximum leverage ratio			300.00%

XML

Business Segment Information (Tables)

9 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Summary Of Financial Information Attributable To Reportable Segments

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Net Sales - Specialty Foods	$	263,400		$	241,849		$	826,798		$	782,267
Operating Income
Specialty Foods	$	34,170		$	31,408		$	124,909		$	130,364
Corporate Expenses	(2,962		)	(2,573		)	(8,881		)	(8,913		)
Total	$	31,208		$	28,835		$	116,028		$	121,451

XML

Summary Of Significant Accounting Policies

9 Months Ended

Mar. 31, 2015

Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and SEC Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the results of operations and financial position for such periods. All such adjustments reflected in the interim condensed consolidated financial statements are considered to be of a normal recurring nature. The results of operations for any interim period are not necessarily indicative of results for the full year. Accordingly, these financial statements should be read in conjunction with the financial statements and notes thereto contained in our 2014 Annual Report on Form 10-K. Prior-year results reflect the classification of the sold candle manufacturing and marketing operations as discontinued operations. Unless otherwise noted, the term “year” and references to a particular year pertain to our fiscal year, which begins on July 1 and ends on June 30; for example, 2015 refers to fiscal 2015, which is the period from July 1, 2014 to June 30, 2015.

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation, except for those acquired as part of a business combination, which are stated at fair value at the time of purchase. Purchases of property, plant and equipment included in accounts payable and excluded from the property additions and the change in accounts payable in the Condensed Consolidated Statements of Cash Flows were as follows:

	March 31,
	2015		2014
Construction in progress in accounts payable	$	489	$	1,465

Accrued Distribution

Accrued distribution costs included in accrued liabilities were $6.1 million and $6.4 million at March 31, 2015 and June 30, 2014, respectively.

Earnings Per Share

Earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock and common stock equivalents (restricted stock and stock-settled stock appreciation rights) outstanding during each period. Unvested shares of restricted stock granted to employees are considered participating securities since employees receive nonforfeitable dividends prior to vesting and, therefore, are included in the earnings allocation in computing EPS under the two-class method. Basic EPS excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing income available to common shareholders by the diluted weighted average number of common shares outstanding during the period, which includes the dilutive potential common shares associated with nonparticipating restricted stock and stock-settled stock appreciation rights.

Basic and diluted income per common share from continuing operations were calculated as follows:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Income from continuing operations	$	20,403		$	18,900		$	76,118		$	80,085
Income from continuing operations available to participating securities	(26		)	(21		)	(109		)	(139		)
Income from continuing operations available to common shareholders	$	20,377		$	18,879		$	76,009		$	79,946
Weighted average common shares outstanding – basic	27,303			27,261			27,294			27,258
Incremental share effect from:
Nonparticipating restricted stock	2			2			3			3
Stock-settled stock appreciation rights	25			34			26			42
Weighted average common shares outstanding – diluted	27,330			27,297			27,323			27,303
Income per common share from continuing operations – basic and diluted	$	0.75		$	0.69		$	2.78		$	2.93

Reclassifications Out of Accumulated Other Comprehensive Loss

The following table presents the amounts reclassified out of accumulated other comprehensive loss by component:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Accumulated other comprehensive loss at beginning of period	$	(7,936	)	$	(8,256	)	$	(8,061	)	$	(8,391	)
Defined Benefit Pension Plan Items:
Amortization of unrecognized net loss (1)	107			115			321			345
Postretirement Benefit Plan Items:
Amortization of unrecognized net gain (1)	(7		)	(6		)	(21		)	(20		)
Amortization of prior service asset (1)	(1		)	(1		)	(3		)	(3		)
Total other comprehensive income, before tax	99			108			297			322
Total tax expense	(37		)	(40		)	(110		)	(119		)
Other comprehensive income, net of tax	62			68			187			203
Accumulated other comprehensive loss at end of period	$	(7,874	)	$	(8,188	)	$	(7,874	)	$	(8,188	)

(1) Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

Significant Accounting Policies

There were no changes to our Significant Accounting Policies from those disclosed in our 2014 Annual Report on Form 10-K.

Recently Issued Accounting Standards

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (“ASU 14-09”) which creates a comprehensive set of guidelines for the recognition of revenue under the principle: “Recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” The requirements of ASU 14-09 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2016 and will require either retrospective application to each prior period presented or retrospective application with the cumulative effect of initially applying the standard recognized at the date of adoption. We are currently evaluating the impact this ASU will have on our financial position and results of operations.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Jun. 30, 2014
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 194	$ 432
Preferred stock, shares authorized	3,050,000	3,050,000
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares outstanding	27,356,804	27,339,421

XML

Summary Of Significant Accounting Policies (Policy)

9 Months Ended

Mar. 31, 2015

Accounting Policies [Abstract]

Basis Of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and SEC Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the results of operations and financial position for such periods. All such adjustments reflected in the interim condensed consolidated financial statements are considered to be of a normal recurring nature. The results of operations for any interim period are not necessarily indicative of results for the full year. Accordingly, these financial statements should be read in conjunction with the financial statements and notes thereto contained in our 2014 Annual Report on Form 10-K. Prior-year results reflect the classification of the sold candle manufacturing and marketing operations as discontinued operations. Unless otherwise noted, the term “year” and references to a particular year pertain to our fiscal year, which begins on July 1 and ends on June 30; for example, 2015 refers to fiscal 2015, which is the period from July 1, 2014 to June 30, 2015.

Property, Plant And Equipment

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation, except for those acquired as part of a business combination, which are stated at fair value at the time of purchase.

Earnings Per Share

Earnings Per Share

Earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock and common stock equivalents (restricted stock and stock-settled stock appreciation rights) outstanding during each period. Unvested shares of restricted stock granted to employees are considered participating securities since employees receive nonforfeitable dividends prior to vesting and, therefore, are included in the earnings allocation in computing EPS under the two-class method. Basic EPS excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing income available to common shareholders by the diluted weighted average number of common shares outstanding during the period, which includes the dilutive potential common shares associated with nonparticipating restricted stock and stock-settled stock appreciation rights.

Recently Issued Accounting Standards

Recently Issued Accounting Standards

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (“ASU 14-09”) which creates a comprehensive set of guidelines for the recognition of revenue under the principle: “Recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” The requirements of ASU 14-09 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2016 and will require either retrospective application to each prior period presented or retrospective application with the cumulative effect of initially applying the standard recognized at the date of adoption. We are currently evaluating the impact this ASU will have on our financial position and results of operations.

XML

Document And Entity Information In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Apr. 24, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000057515
Entity Registrant Name	LANCASTER COLONY CORP
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		27,357
Document Period End Date	Mar. 31, 2015
Document Fiscal Year Focus	2015
Current Fiscal Year End Date	--06-30

XML

Summary Of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2015

Accounting Policies [Abstract]

Schedule Of Construction In Progress In Accounts Payable

Purchases of property, plant and equipment included in accounts payable and excluded from the property additions and the change in accounts payable in the Condensed Consolidated Statements of Cash Flows were as follows:

	March 31,
	2015		2014
Construction in progress in accounts payable	$	489	$	1,465

Schedule Of Basic And Diluted Income Per Common Share From Continuing Operations Calculations

Basic and diluted income per common share from continuing operations were calculated as follows:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Income from continuing operations	$	20,403		$	18,900		$	76,118		$	80,085
Income from continuing operations available to participating securities	(26		)	(21		)	(109		)	(139		)
Income from continuing operations available to common shareholders	$	20,377		$	18,879		$	76,009		$	79,946
Weighted average common shares outstanding – basic	27,303			27,261			27,294			27,258
Incremental share effect from:
Nonparticipating restricted stock	2			2			3			3
Stock-settled stock appreciation rights	25			34			26			42
Weighted average common shares outstanding – diluted	27,330			27,297			27,323			27,303
Income per common share from continuing operations – basic and diluted	$	0.75		$	0.69		$	2.78		$	2.93

Schedule Of Amounts Reclassified Out Of Accumulated Other Comprehensive Loss

The following table presents the amounts reclassified out of accumulated other comprehensive loss by component:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Accumulated other comprehensive loss at beginning of period	$	(7,936	)	$	(8,256	)	$	(8,061	)	$	(8,391	)
Defined Benefit Pension Plan Items:
Amortization of unrecognized net loss (1)	107			115			321			345
Postretirement Benefit Plan Items:
Amortization of unrecognized net gain (1)	(7		)	(6		)	(21		)	(20		)
Amortization of prior service asset (1)	(1		)	(1		)	(3		)	(3		)
Total other comprehensive income, before tax	99			108			297			322
Total tax expense	(37		)	(40		)	(110		)	(119		)
Other comprehensive income, net of tax	62			68			187			203
Accumulated other comprehensive loss at end of period	$	(7,874	)	$	(8,188	)	$	(7,874	)	$	(8,188	)

(1) Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

XML

Condensed Consolidated Statements Of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Net Sales	$ 263,400	$ 241,849	$ 826,798	$ 782,267
Cost of Sales	206,775	189,941	634,096	591,565
Gross Margin	56,625	51,908	192,702	190,702
Selling, General and Administrative Expenses	25,417	23,073	76,674	69,251
Operating Income	31,208	28,835	116,028	121,451
Interest Income and Other-Net	(138)	(204)	(177)	(328)
Income From Continuing Operations Before Income Taxes	31,070	28,631	115,851	121,123
Taxes Based on Income	10,667	9,731	39,733	41,038
Income From Continuing Operations	20,403	18,900	76,118	80,085
Discontinued Operations, Net of Tax:
Income from discontinued operations	0	325	0	3,175
Loss on sale of discontinued operations	0	(29,601)	0	(29,601)
Total discontinued operations	0	(29,276)	0	(26,426)
Net Income (Loss)	$ 20,403	$ (10,376)	$ 76,118	$ 53,659
Income Per Common Share From Continuing Operations:
Basic and diluted (in dollars per share)	$ 0.75	$ 0.69	$ 2.78	$ 2.93
Loss Per Common Share From Discontinued Operations:
Basic and diluted (in dollars per share)	$ 0.00	$ (1.07)	$ 0.00	$ (0.97)
Net Income (Loss) Per Common Share:
Basic (in dollars per share)	$ 0.75	$ (0.38)	$ 2.78	$ 1.97
Diluted (in dollars per share)	$ 0.75	$ (0.38)	$ 2.78	$ 1.96
Cash Dividends Per Common Share (in dollars per share)	$ 0.46	$ 0.44	$ 1.36	$ 1.28
Weighted Average Common Shares Outstanding:
Basic (in shares)	27,303	27,261	27,294	27,258
Diluted (in shares)	27,330	27,297	27,323	27,303

XML

Stock-Based Compensation

9 Months Ended

Mar. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation

Stock-Based Compensation

Our shareholders previously approved the adoption of and subsequent amendments to the Lancaster Colony Corporation 2005 Stock Plan (the “2005 Plan”). The 2005 Plan reserved 2,000,000 common shares for issuance to our employees and directors, and all awards granted under the 2005 Plan will be exercisable at prices not less than fair market value as of the date of the grant. The vesting period for awards granted under the 2005 Plan varies as to the type of award granted, but generally these awards have a maximum term of five years.

Stock-Settled Stock Appreciation Rights

We use periodic grants of stock-settled stock appreciation rights (“SSSARs”) as a vehicle for rewarding certain employees with long-term incentives for their efforts in helping to create long-term shareholder value. We calculate the fair value of SSSARs grants using the Black-Scholes option-pricing model. Our policy is to issue shares upon SSSARs exercise from new shares that had been previously authorized.

In the nine months ended March 31, 2015 and 2014, we granted SSSARs under the terms of the 2005 Plan. The following table summarizes information relating to these grants:

	Nine Months Ended   March 31,
	2015			2014
SSSARs granted	149			146
Weighted average grant date fair value per right	$	9.94		$	11.84
Weighted average assumptions used in fair value calculations:
Risk-free interest rate	0.86		%	0.75		%
Dividend yield	2.02		%	1.97		%
Volatility factor of the expected market price of our common stock	19.62		%	22.35		%
Weighted average expected life in years	2.71			3.12

For these grants, the volatility factor was estimated based on actual historical volatility of our stock for a time period equal to the term of the SSSARs. The expected average life was determined based on historical exercise experience for this type of grant. The SSSARs we grant vest one-third on the first anniversary of the grant date, one-third on the second anniversary of the grant date and one-third on the third anniversary of the grant date. As needed, we estimate a forfeiture rate for our SSSARs grants based on historical experience.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification. We recorded tax benefits and excess tax benefits related to SSSARs. These excess tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes our continuing operations SSSARs compensation expense and tax benefits recorded:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Compensation expense	$	308	$	304	$	893	$	804
Tax benefits	$	108	$	106	$	313	$	281
Intrinsic value of exercises	$	207	$	2,343	$	863	$	2,431
Excess tax benefits	$	72	$	820	$	302	$	851

The total fair values of SSSARs vested were as follows:

	Nine Months Ended   March 31,
	2015		2014
Fair value of vested rights	$	1,245	$	1,138

The following table summarizes the activity relating to SSSARs granted under the 2005 Plan for the nine months ended March 31, 2015:

	Number of Rights		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of year	358		$	76.75
Exercised	(54	)	$	63.54
Granted	149		$	91.13
Forfeited	(31	)	$	79.42
Outstanding at end of period	422		$	83.35	3.73	$	4,984
Exercisable and vested at end of period	154		$	74.70	2.66	$	3,150
Vested and expected to vest at end of period	412		$	83.35	3.73	$	4,873

At March 31, 2015, there was $2.3 million of unrecognized compensation expense related to SSSARs that we will recognize over a weighted-average period of 2 years.

Restricted Stock

We use periodic grants of restricted stock as a vehicle for rewarding our nonemployee directors and certain employees with long-term incentives for their efforts in helping to create long-term shareholder value.

In the nine months ended March 31, 2015 and 2014, we granted shares of restricted stock to various employees under the terms of the 2005 Plan. The following table summarizes information relating to these grants:

	Nine Months Ended   March 31,
	2015		2014
Employees
Restricted stock granted	9		24
Grant date fair value	$	845	$	2,190
Weighted average grant date fair value per award	$	91.13	$	89.21

The restricted stock under these employee grants vests on the third anniversary of the grant date. As needed, we estimate a forfeiture rate for our restricted stock grants based on historical experience. Under the terms of our grants, employees receive dividends on unforfeited restricted stock regardless of their vesting status. In the nine months ended March 31, 2015 and 2014, 19,000 and 6,000 shares, respectively, of employee restricted stock vested.

In November 2014 and 2013, we granted shares of restricted stock to our nonemployee directors under the terms of the 2005 Plan. The following table summarizes information relating to each of these grants:

	Nine Months Ended   March 31,
	2015		2014
Nonemployee directors
Restricted stock granted	7		6
Grant date fair value	$	639	$	490
Weighted average grant date fair value per award	$	92.92	$	84.42

The 2015 grant vests over a one-year period, and all of these shares are expected to vest. Dividends earned on the stock during the vesting period will be paid to the directors at the time the stock vests. In the nine months ended March 31, 2015 and 2014, 6,000 and 7,000 shares, respectively, of nonemployee director restricted stock vested, and the directors were paid the related dividends.

We recognize compensation expense over the requisite service period. Compensation expense was reflected in Cost of Sales or Selling, General and Administrative Expenses based on the grantees’ salaries expense classification. We recorded tax benefits and excess tax benefits related to restricted stock. These excess tax benefits were included in the financing section of the Condensed Consolidated Statements of Cash Flows. The following table summarizes our continuing operations restricted stock compensation expense and tax benefits recorded:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Compensation expense	$	384	$	366	$	1,318	$	1,027
Tax benefits	$	134	$	128	$	461	$	359
Excess tax benefits	$	142	$	68	$	154	$	76

The total fair values of restricted stock vested were as follows:

	Nine Months Ended   March 31,
	2015		2014
Fair value of vested shares	$	1,818	$	877

The following table summarizes the activity relating to restricted stock granted under the 2005 Plan for the nine months ended March 31, 2015:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of year	58		$	79.09
Granted	16		$	91.89
Vested	(25	)	$	71.86
Forfeited	(3	)	$	79.22
Unvested restricted stock at end of period	46		$	87.61

At March 31, 2015, there was $2.6 million of unrecognized compensation expense related to restricted stock that we will recognize over a weighted-average period of 2 years.

XML

Income Taxes

9 Months Ended

Mar. 31, 2015

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Prepaid Federal, state and local income taxes of $10.3 million and $9.7 million were included in deferred income taxes and other current assets at March 31, 2015 and June 30, 2014, respectively.

The gross tax contingency reserve at March 31, 2015 was $1.0 million and consisted of tax liabilities of $0.6 million and interest and penalties of $0.4 million. We have not classified any of the gross tax contingency reserve as current liabilities as none of these amounts are expected to be resolved within the next 12 months. The entire liability of $1.0 million was included in other noncurrent liabilities. We expect that the amount of these liabilities will change within the next 12 months; however, we do not expect the change to have a significant effect on our financial position or results of operations. We recognize interest and penalties related to these tax liabilities in income tax expense.

XML

Postretirement Benefits (Tables) (Postretirement Benefits [Member])

9 Months Ended

Mar. 31, 2015

Postretirement Benefits [Member]

Defined Benefit Plan Disclosure [Line Items]

Components Of Net Periodic Benefit Cost

The following table summarizes the components of net periodic benefit cost for our postretirement plans:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Components of net periodic benefit cost
Service cost	$	8		$	8		$	24		$	24
Interest cost	27			33			81			97
Amortization of unrecognized net gain	(7		)	(6		)	(21		)	(20		)
Amortization of prior service asset	(1		)	(1		)	(3		)	(3		)
Net periodic benefit cost	$	27		$	34		$	81		$	98

XML

Acquisition (Tables)

9 Months Ended

Mar. 31, 2015

Business Combinations [Abstract]

Schedule Of Purchase Price Allocation

The following preliminary purchase price allocation is based on the estimated fair value of the net assets acquired, as adjusted for the estimate of the final net working capital of $0.2 million recorded as of March 31:

Balance Sheet Captions	Allocation
Receivables	$	2,532
Inventories	3,748
Other current assets	512
Property, plant and equipment	7,198
Goodwill (not tax deductible)	36,883
Other intangible assets	47,100
Current liabilities	(2,310		)
Deferred tax liabilities	(3,225		)
Net assets acquired	$	92,438

XML

Commitments And Contingencies

9 Months Ended

Mar. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments And Contingencies

Commitments and Contingencies

At March 31, 2015, we were a party to various claims and litigation matters arising in the ordinary course of business. Such matters did not have a material effect on the current-year results of operations and, in our opinion, their ultimate disposition will not have a material effect on our consolidated financial statements.

XML

Pension Benefits (Pension Benefits [Member])

9 Months Ended

Mar. 31, 2015

Pension Benefits [Member]

Defined Benefit Plan Disclosure [Line Items]

Pension Benefits

Pension Benefits

We sponsor multiple defined benefit pension plans that covered certain union workers. However, as a result of prior-years' restructuring activities, for all periods presented, we no longer have any active employees continuing to accrue service cost or otherwise eligible to receive plan benefits. Benefits being paid under the plans are primarily based on negotiated rates and years of service. We contribute to these plans at least the minimum amount required by regulation.

The following table summarizes the components of net periodic benefit income for our pension plans:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Components of net periodic benefit income
Interest cost	$	403		$	439		$	1,209		$	1,315
Expected return on plan assets	(658		)	(614		)	(1,974		)	(1,842		)
Amortization of unrecognized net loss	107			115			321			345
Net periodic benefit income	$	(148	)	$	(60	)	$	(444	)	$	(182	)

For the three and nine months ended March 31, 2015, we made no pension plan contributions and we do not expect to make any contributions to our pension plans during 2015.

XML

Postretirement Benefits (Postretirement Benefits [Member])

9 Months Ended

Mar. 31, 2015

Postretirement Benefits [Member]

Defined Benefit Plan Disclosure [Line Items]

Postretirement Benefits

Postretirement Benefits

We and certain of our operating subsidiaries provide multiple postretirement medical and life insurance benefit plans. We recognize the cost of benefits as the employees render service. Postretirement benefits are funded as incurred.

The following table summarizes the components of net periodic benefit cost for our postretirement plans:

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Components of net periodic benefit cost
Service cost	$	8		$	8		$	24		$	24
Interest cost	27			33			81			97
Amortization of unrecognized net gain	(7		)	(6		)	(21		)	(20		)
Amortization of prior service asset	(1		)	(1		)	(3		)	(3		)
Net periodic benefit cost	$	27		$	34		$	81		$	98

For the three and nine months ended March 31, 2015, we made $20,000 and $74,000, respectively, in contributions to our postretirement medical and life insurance benefit plans. We expect to make approximately $0.1 million more in contributions to our postretirement medical and life insurance benefit plans during the remainder of 2015.

XML

Business Segment Information

9 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Business Segment Information

Business Segment Information

The following summary of financial information by business segment is consistent with the basis of segmentation and measurement of segment profit or loss presented in our June 30, 2014 consolidated financial statements. The March 31, 2015 identifiable assets by reportable segment are generally consistent with that of June 30, 2014. However, due to the acquisition of Flatout in March 2015, the amount of Specialty Foods assets increased and Corporate assets declined as compared to June 30, 2014. The increase in Specialty Foods assets reflects goodwill and other intangible assets related to the acquisition of Flatout. Corporate assets declined because of a decrease in cash, which is treated as a Corporate asset, due to cash paid for the acquisition of Flatout.

	Three Months Ended   March 31,						Nine Months Ended   March 31,
	2015			2014			2015			2014
Net Sales - Specialty Foods	$	263,400		$	241,849		$	826,798		$	782,267
Operating Income
Specialty Foods	$	34,170		$	31,408		$	124,909		$	130,364
Corporate Expenses	(2,962		)	(2,573		)	(8,881		)	(8,913		)
Total	$	31,208		$	28,835		$	116,028		$	121,451

XML

Goodwill And Other Intangible Assets (Schedule Of Amortization Expense) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 308	$ 236	$ 780	$ 709

XML

Postretirement Benefits (Components Of Net Periodic Benefit Cost) (Details) (Postretirement Benefits [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended				9 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Mar. 31, 2015		Mar. 31, 2014
Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 8		$ 8		$ 24		$ 24
Interest cost	27		33		81		97
Amortization of unrecognized net (gain) loss	(7)	[1]	(6)	[1]	(21)	[1]	(20)	[1]
Amortization of prior service asset	(1)	[1]	(1)	[1]	(3)	[1]	(3)	[1]
Net periodic benefit (income) cost	$ 27		$ 34		$ 81		$ 98

[1] Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

XML

Stock-Based Compensation (Tables)

9 Months Ended

Mar. 31, 2015

Stock Settled Stock Appreciation Rights SARS [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-Based Compensation Grant Details

In the nine months ended March 31, 2015 and 2014, we granted SSSARs under the terms of the 2005 Plan. The following table summarizes information relating to these grants:

	Nine Months Ended   March 31,
	2015			2014
SSSARs granted	149			146
Weighted average grant date fair value per right	$	9.94		$	11.84
Weighted average assumptions used in fair value calculations:
Risk-free interest rate	0.86		%	0.75		%
Dividend yield	2.02		%	1.97		%
Volatility factor of the expected market price of our common stock	19.62		%	22.35		%
Weighted average expected life in years	2.71			3.12

Compensation Expense And Tax Benefits Recorded

The following table summarizes our continuing operations SSSARs compensation expense and tax benefits recorded:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Compensation expense	$	308	$	304	$	893	$	804
Tax benefits	$	108	$	106	$	313	$	281
Intrinsic value of exercises	$	207	$	2,343	$	863	$	2,431
Excess tax benefits	$	72	$	820	$	302	$	851

Fair Value Of Awards Vested

The total fair values of SSSARs vested were as follows:

	Nine Months Ended   March 31,
	2015		2014
Fair value of vested rights	$	1,245	$	1,138

Stock-Settled Stock Appreciation Rights Activity

The following table summarizes the activity relating to SSSARs granted under the 2005 Plan for the nine months ended March 31, 2015:

	Number of Rights		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of year	358		$	76.75
Exercised	(54	)	$	63.54
Granted	149		$	91.13
Forfeited	(31	)	$	79.42
Outstanding at end of period	422		$	83.35	3.73	$	4,984
Exercisable and vested at end of period	154		$	74.70	2.66	$	3,150
Vested and expected to vest at end of period	412		$	83.35	3.73	$	4,873

Employee Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-Based Compensation Grant Details

In the nine months ended March 31, 2015 and 2014, we granted shares of restricted stock to various employees under the terms of the 2005 Plan. The following table summarizes information relating to these grants:

	Nine Months Ended   March 31,
	2015		2014
Employees
Restricted stock granted	9		24
Grant date fair value	$	845	$	2,190
Weighted average grant date fair value per award	$	91.13	$	89.21

Director Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-Based Compensation Grant Details

In November 2014 and 2013, we granted shares of restricted stock to our nonemployee directors under the terms of the 2005 Plan. The following table summarizes information relating to each of these grants:

	Nine Months Ended   March 31,
	2015		2014
Nonemployee directors
Restricted stock granted	7		6
Grant date fair value	$	639	$	490
Weighted average grant date fair value per award	$	92.92	$	84.42

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation Expense And Tax Benefits Recorded

The following table summarizes our continuing operations restricted stock compensation expense and tax benefits recorded:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Compensation expense	$	384	$	366	$	1,318	$	1,027
Tax benefits	$	134	$	128	$	461	$	359
Excess tax benefits	$	142	$	68	$	154	$	76

Fair Value Of Awards Vested

The total fair values of restricted stock vested were as follows:

	Nine Months Ended   March 31,
	2015		2014
Fair value of vested shares	$	1,818	$	877

Restricted Stock Activity

The following table summarizes the activity relating to restricted stock granted under the 2005 Plan for the nine months ended March 31, 2015:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of year	58		$	79.09
Granted	16		$	91.89
Vested	(25	)	$	71.86
Forfeited	(3	)	$	79.22
Unvested restricted stock at end of period	46		$	87.61

XML

Summary Of Significant Accounting Policies (Schedule Of Construction In Progress In Accounts Payable) (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Accounting Policies [Abstract]
Construction in progress in accounts payable	$ 489	$ 1,465

XML

Pension Benefits (Components Of Net Periodic Benefit Income) (Details) (Pension Benefits [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended				9 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Mar. 31, 2015		Mar. 31, 2014
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 403		$ 439		$ 1,209		$ 1,315
Expected return on plan assets	(658)		(614)		(1,974)		(1,842)
Amortization of unrecognized net loss	107	[1]	115	[1]	321	[1]	345	[1]
Net periodic benefit (income) cost	$ (148)		$ (60)		$ (444)		$ (182)

[1] Included in the computation of net periodic benefit income/cost. See Notes 7 and 8 for additional information.

XML

Stock-Based Compensation (Fair Value Of Stock-Settled Stock Appreciation Rights Vested) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested rights	$ 1,245	$ 1,138

XML

Condensed Consolidated Statements Of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ 20,403	$ (10,376)	$ 76,118	$ 53,659
Defined Benefit Pension and Postretirement Benefit Plans:
Amortization of loss, before tax	100	109	300	325
Amortization of prior service asset, before tax	(1)	(1)	(3)	(3)
Total Other Comprehensive Income, Before Tax	99	108	297	322
Tax Attributes of Items in Other Comprehensive Income:
Amortization of loss, tax	(38)	(41)	(111)	(120)
Amortization of prior service asset, tax	1	1	1	1
Total Tax Expense	(37)	(40)	(110)	(119)
Other Comprehensive Income, Net of Tax	62	68	187	203
Comprehensive Income (Loss)	$ 20,465	$ (10,308)	$ 76,305	$ 53,862

XML

Long-Term Debt

9 Months Ended

Mar. 31, 2015

Debt Disclosure [Abstract]

Long-Term Debt

Long-Term Debt

At March 31, 2015 and June 30, 2014, we had an unsecured credit facility (“Facility”) under which we may borrow, on a revolving credit basis, up to a maximum of $120 million at any one time, with potential to expand the total credit availability to $200 million based on obtaining consent of the issuing banks and certain other conditions. The Facility expires on April 18, 2017, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to LIBOR or an alternative base rate defined in the credit agreement, at our option. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Based on the long-term nature of this Facility, when we have outstanding borrowings under this Facility, they will be classified as long-term debt.

At March 31, 2015 and June 30, 2014, we had no borrowings outstanding under this Facility. At March 31, 2015, we had $4.2 million of standby letters of credit outstanding, which reduced the amount available for borrowing on the Facility. We paid no interest for the three and nine months ended March 31, 2015 and 2014. At March 31, 2015 and June 30, 2014, we exceeded the requirements of the financial covenants by substantial margins.

The Facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions. There are two principal financial covenants: an interest expense test that requires us to maintain an interest coverage ratio not less than 2.5 to 1 at the end of each fiscal quarter; and an indebtedness test that requires us to maintain a consolidated leverage ratio not greater than 3 to 1 at all times. The interest coverage ratio is calculated by dividing Consolidated EBIT (as defined more specifically in the credit agreement) by Consolidated Interest Expense (as defined more specifically in the credit agreement), and the leverage ratio is calculated by dividing Consolidated Debt (as defined more specifically in the credit agreement) by Consolidated EBITDA (as defined more specifically in the credit agreement).

XML

Summary Of Significant Accounting Policies (Schedule Of Basic And Diluted Income Per Common Share From Continuing Operations Calculations) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Accounting Policies [Abstract]
Income from continuing operations	$ 20,403	$ 18,900	$ 76,118	$ 80,085
Income from continuing operations available to participating securities	(26)	(21)	(109)	(139)
Income from continuing operations available to common shareholders	$ 20,377	$ 18,879	$ 76,009	$ 79,946
Weighted average common shares outstanding - basic (in shares)	27,303	27,261	27,294	27,258
Incremental share effect from:
Nonparticipating restricted stock (in shares)	2	2	3	3
Stock-settled stock appreciation rights (in shares)	25	34	26	42
Weighted average common shares outstanding - diluted (in shares)	27,330	27,297	27,323	27,303
Income per common share from continuing operations - basic and diluted (in dollars per share)	$ 0.75	$ 0.69	$ 2.78	$ 2.93

XML

Stock-Based Compensation (Narrative) (Details) (USD $) In Millions, except Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Unrecognized compensation cost	2.3
Weighted-average period over which remaining compensation cost will be recognized	2 years
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	2.6
Weighted-average period over which remaining compensation cost will be recognized	2 years
Number vested (in shares)	25,000
Employee Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Number vested (in shares)	19,000	6,000
Director Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Number vested (in shares)	6,000	7,000
2005 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common shares reserved for issuance to employees and directors (in shares)	2,000,000
2005 Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum term of stock awards granted	5 years

XML

Goodwill And Other Intangible Assets (Tables)

9 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Rollforward Of Goodwill

The following table is a rollforward of goodwill from June 30, 2014 to March 31, 2015:

	Carrying Value
Goodwill at beginning of year	$	89,840
Goodwill acquired during the period	36,883
Goodwill at end of period	$	126,723

Summary Of Other Intangible Assets

The following table summarizes our identifiable other intangible assets, all included in the Specialty Foods segment. The intangible asset values and lives related to the Flatout acquisition, which are included in the table below, are preliminary and subject to further review over the measurement period. See further discussion in Note 2.

	March 31,   2015			June 30,   2014
Tradename (indefinite life)
Gross carrying value	$	37,600		$	—
Trademarks (40-year life)
Gross carrying value	$	370		$	370
Accumulated amortization	(221		)	(214		)
Net carrying value	$	149		$	156
Customer Relationships (10 to 15-year life)
Gross carrying value	$	18,020		$	13,020
Accumulated amortization	(8,531		)	(7,800		)
Net carrying value	$	9,489		$	5,220
Technology / Know-how (10-year life)
Gross carrying value	$	3,900		$	—
Accumulated amortization	(32		)	—
Net carrying value	$	3,868		$	—
Non-compete Agreements (5-year life)
Gross carrying value	$	600		$	—
Accumulated amortization	(10		)	—
Net carrying value	$	590		$	—
Total net carrying value	$	51,696		$	5,376

Schedule Of Amortization Expense

Amortization expense for our other intangible assets was as follows:

	Three Months Ended   March 31,				Nine Months Ended   March 31,
	2015		2014		2015		2014
Amortization expense	$	308	$	236	$	780	$	709

Estimated Annual Amortization Expense

Total annual amortization expense for each of the next five years is estimated to be as follows:

2016	$	1,785
2017	$	1,614
2018	$	1,614
2019	$	1,614
2020	$	1,574